| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cytochrome P-450 Enzyme System | 8 | 2018 | 144 | 3.76 | Why? |
| Triticum | 9 | 2018 | 54 | 3.46 | Why? |
| Polymorphism, Single Nucleotide | 24 | 2019 | 3607 | 2.88 | Why? |
| MicroRNAs | 15 | 2019 | 1787 | 2.44 | Why? |
| Cell Proliferation | 16 | 2019 | 1973 | 2.04 | Why? |
| Signal Transduction | 29 | 2020 | 7207 | 1.92 | Why? |
| Genes, Plant | 6 | 2018 | 42 | 1.87 | Why? |
| Phenylurea Compounds | 4 | 2020 | 101 | 1.68 | Why? |
| RNA, Long Noncoding | 4 | 2019 | 408 | 1.68 | Why? |
| Eicosanoids | 4 | 2018 | 64 | 1.65 | Why? |
| Proto-Oncogene Proteins c-akt | 7 | 2018 | 372 | 1.62 | Why? |
| Epithelial-Mesenchymal Transition | 6 | 2019 | 242 | 1.53 | Why? |
| Plant Proteins | 4 | 2018 | 194 | 1.49 | Why? |
| Insulin Resistance | 4 | 2018 | 669 | 1.48 | Why? |
| Diabetic Cardiomyopathies | 3 | 2018 | 79 | 1.47 | Why? |
| Glycogen Synthase Kinase 3 beta | 2 | 2018 | 45 | 1.41 | Why? |
| Genetic Predisposition to Disease | 17 | 2019 | 4027 | 1.37 | Why? |
| Infant Nutritional Physiological Phenomena | 2 | 2017 | 75 | 1.35 | Why? |
| Cell Movement | 10 | 2019 | 695 | 1.33 | Why? |
| Epoxide Hydrolases | 4 | 2020 | 21 | 1.32 | Why? |
| Apoptosis | 13 | 2019 | 2335 | 1.31 | Why? |
| Gene Expression Regulation, Neoplastic | 8 | 2019 | 1014 | 1.28 | Why? |
| Genetic Testing | 3 | 2019 | 395 | 1.28 | Why? |
| Prenatal Diagnosis | 6 | 2018 | 345 | 1.27 | Why? |
| Heart Failure | 9 | 2020 | 6638 | 1.22 | Why? |
| Genome, Plant | 4 | 2018 | 41 | 1.19 | Why? |
| Stomach Neoplasms | 4 | 2019 | 477 | 1.18 | Why? |
| Lipid Metabolism | 4 | 2018 | 572 | 1.13 | Why? |
| Piperidines | 4 | 2020 | 795 | 1.13 | Why? |
| Child Development | 4 | 2017 | 352 | 1.13 | Why? |
| Myeloid-Derived Suppressor Cells | 2 | 2019 | 316 | 1.11 | Why? |
| Chromosome Disorders | 3 | 2018 | 24 | 1.08 | Why? |
| Nitric Oxide Synthase Type III | 4 | 2019 | 87 | 1.08 | Why? |
| Promoter Regions, Genetic | 8 | 2019 | 823 | 1.08 | Why? |
| Mice, Inbred C57BL | 22 | 2020 | 5542 | 1.07 | Why? |
| Gliadin | 3 | 2018 | 26 | 1.06 | Why? |
| Chromosome Aberrations | 3 | 2018 | 54 | 1.05 | Why? |
| Gene Expression Regulation | 14 | 2019 | 4020 | 1.04 | Why? |
| Ethanol | 2 | 2018 | 533 | 0.96 | Why? |
| Mice | 35 | 2020 | 21357 | 0.95 | Why? |
| Angiotensin II | 4 | 2019 | 601 | 0.94 | Why? |
| Biofilms | 4 | 2017 | 304 | 0.94 | Why? |
| Quantitative Trait, Heritable | 2 | 2018 | 26 | 0.93 | Why? |
| Genetic Markers | 3 | 2018 | 318 | 0.93 | Why? |
| Electronic Health Records | 12 | 2018 | 3492 | 0.92 | Why? |
| Edible Grain | 2 | 2018 | 26 | 0.92 | Why? |
| Myocytes, Cardiac | 7 | 2018 | 804 | 0.92 | Why? |
| Hyphae | 3 | 2017 | 22 | 0.92 | Why? |
| Cell Adhesion | 5 | 2019 | 230 | 0.91 | Why? |
| Microarray Analysis | 4 | 2018 | 262 | 0.91 | Why? |
| Animals | 72 | 2020 | 78931 | 0.91 | Why? |
| Candida albicans | 3 | 2017 | 217 | 0.90 | Why? |
| NF-kappa B | 6 | 2019 | 1301 | 0.88 | Why? |
| Myocarditis | 4 | 2020 | 2731 | 0.88 | Why? |
| Cells, Cultured | 15 | 2019 | 5835 | 0.87 | Why? |
| Liver Neoplasms | 5 | 2019 | 1666 | 0.87 | Why? |
| Macrophages | 6 | 2020 | 2784 | 0.87 | Why? |
| Diabetes Mellitus, Experimental | 3 | 2018 | 192 | 0.87 | Why? |
| Poaceae | 2 | 2017 | 23 | 0.87 | Why? |
| Insulins | 1 | 2020 | 26 | 0.86 | Why? |
| Alleles | 10 | 2018 | 1557 | 0.85 | Why? |
| Osteogenesis | 2 | 2018 | 95 | 0.85 | Why? |
| Endothelial Cells | 5 | 2019 | 2048 | 0.85 | Why? |
| Neovascularization, Physiologic | 2 | 2018 | 160 | 0.85 | Why? |
| Mitochondria | 2 | 2018 | 857 | 0.84 | Why? |
| Nutritive Value | 2 | 2018 | 100 | 0.84 | Why? |
| Osteoblasts | 2 | 2017 | 87 | 0.84 | Why? |
| Arabidopsis | 2 | 2018 | 88 | 0.84 | Why? |
| Glutens | 2 | 2018 | 55 | 0.84 | Why? |
| Response Elements | 2 | 2018 | 54 | 0.83 | Why? |
| Uterine Cervical Neoplasms | 3 | 2019 | 842 | 0.83 | Why? |
| Transcription Factor RelA | 2 | 2018 | 122 | 0.82 | Why? |
| Rats | 13 | 2019 | 2764 | 0.82 | Why? |
| SOXF Transcription Factors | 1 | 2019 | 6 | 0.82 | Why? |
| Natural Language Processing | 4 | 2018 | 436 | 0.82 | Why? |
| Carcinoma, Hepatocellular | 3 | 2019 | 1222 | 0.82 | Why? |
| Biomarkers, Tumor | 7 | 2019 | 1314 | 0.81 | Why? |
| Seeds | 2 | 2017 | 114 | 0.81 | Why? |
| Ticlopidine | 3 | 2019 | 193 | 0.81 | Why? |
| Phytophthora | 1 | 2019 | 4 | 0.80 | Why? |
| Mammary Glands, Animal | 1 | 2019 | 9 | 0.80 | Why? |
| Aspartic Acid Proteases | 1 | 2019 | 3 | 0.80 | Why? |
| Mitochondrial Proteins | 2 | 2018 | 152 | 0.80 | Why? |
| Nod1 Signaling Adaptor Protein | 1 | 2019 | 23 | 0.79 | Why? |
| Endotoxemia | 2 | 2018 | 143 | 0.79 | Why? |
| Sirtuin 2 | 1 | 2018 | 8 | 0.79 | Why? |
| Alprostadil | 1 | 2018 | 8 | 0.78 | Why? |
| N-Acetylglucosaminyltransferases | 1 | 2018 | 16 | 0.78 | Why? |
| Trimetazidine | 1 | 2018 | 5 | 0.78 | Why? |
| Pseudolymphoma | 1 | 2018 | 11 | 0.78 | Why? |
| Death-Associated Protein Kinases | 1 | 2018 | 8 | 0.77 | Why? |
| White Coat Hypertension | 1 | 2018 | 24 | 0.76 | Why? |
| Reactive Oxygen Species | 5 | 2019 | 1136 | 0.76 | Why? |
| Tooth Movement Techniques | 1 | 2018 | 19 | 0.76 | Why? |
| Chemokine CCL4 | 1 | 2019 | 71 | 0.76 | Why? |
| Arachidonic Acids | 1 | 2018 | 36 | 0.76 | Why? |
| Photoreceptor Cells, Vertebrate | 1 | 2018 | 2 | 0.76 | Why? |
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 54 | 0.76 | Why? |
| Drug Resistance, Neoplasm | 3 | 2019 | 447 | 0.76 | Why? |
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2019 | 71 | 0.75 | Why? |
| Central Nervous System Agents | 1 | 2018 | 45 | 0.75 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2019 | 127 | 0.75 | Why? |
| Arachidonic Acid | 1 | 2018 | 90 | 0.75 | Why? |
| Zinc Transporter 8 | 1 | 2018 | 3 | 0.75 | Why? |
| Nystagmus, Pathologic | 1 | 2018 | 30 | 0.75 | Why? |
| Soybeans | 1 | 2019 | 50 | 0.74 | Why? |
| Vitreoretinopathy, Proliferative | 1 | 2018 | 16 | 0.74 | Why? |
| Fibrillin-1 | 1 | 2017 | 6 | 0.74 | Why? |
| Male | 123 | 2021 | 367725 | 0.74 | Why? |
| Animal Feed | 1 | 2019 | 72 | 0.74 | Why? |
| alpha-Synuclein | 1 | 2018 | 71 | 0.74 | Why? |
| Cathepsin D | 1 | 2017 | 8 | 0.73 | Why? |
| Vibrio parahaemolyticus | 1 | 2017 | 5 | 0.73 | Why? |
| Insulinoma | 1 | 2017 | 9 | 0.73 | Why? |
| Ambroxol | 1 | 2018 | 45 | 0.73 | Why? |
| Inflammation | 12 | 2021 | 13255 | 0.73 | Why? |
| Calpain | 1 | 2018 | 39 | 0.73 | Why? |
| Hypertrophy, Left Ventricular | 2 | 2018 | 219 | 0.73 | Why? |
| Antigens, CD34 | 1 | 2018 | 125 | 0.72 | Why? |
| Gene Expression Profiling | 9 | 2018 | 3788 | 0.72 | Why? |
| Coronary Artery Disease | 6 | 2020 | 2570 | 0.72 | Why? |
| Receptors, LDL | 1 | 2017 | 42 | 0.72 | Why? |
| Adventitia | 1 | 2017 | 3 | 0.72 | Why? |
| Diabetic Neuropathies | 1 | 2018 | 64 | 0.72 | Why? |
| PPAR alpha | 1 | 2018 | 36 | 0.72 | Why? |
| Genotype | 19 | 2019 | 4697 | 0.72 | Why? |
| Flagellin | 1 | 2017 | 22 | 0.72 | Why? |
| Guanine | 1 | 2019 | 146 | 0.72 | Why? |
| Intracranial Hemorrhage, Hypertensive | 1 | 2017 | 4 | 0.72 | Why? |
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2017 | 1 | 0.72 | Why? |
| Antithrombin III Deficiency | 1 | 2017 | 24 | 0.71 | Why? |
| Gene Expression Regulation, Bacterial | 2 | 2018 | 143 | 0.71 | Why? |
| Ochratoxins | 1 | 2017 | 4 | 0.71 | Why? |
| DNA Copy Number Variations | 1 | 2018 | 84 | 0.71 | Why? |
| Heteroptera | 1 | 2017 | 4 | 0.71 | Why? |
| Central Nervous System Depressants | 1 | 2018 | 52 | 0.71 | Why? |
| Retinal Pigment Epithelium | 1 | 2018 | 62 | 0.70 | Why? |
| Diabetes Mellitus, Type 2 | 10 | 2020 | 6166 | 0.70 | Why? |
| Receptors, Purinergic P2Y12 | 1 | 2017 | 42 | 0.70 | Why? |
| Serum Albumin, Human | 1 | 2020 | 265 | 0.70 | Why? |
| Decorin | 1 | 2017 | 14 | 0.70 | Why? |
| Vascular Remodeling | 2 | 2018 | 99 | 0.70 | Why? |
| Glucagon-Like Peptide 1 | 1 | 2018 | 83 | 0.70 | Why? |
| Female | 123 | 2021 | 380317 | 0.70 | Why? |
| Estrogen Receptor Modulators | 1 | 2017 | 27 | 0.70 | Why? |
| Tissue Kallikreins | 1 | 2017 | 3 | 0.70 | Why? |
| Expectorants | 1 | 2018 | 95 | 0.70 | Why? |
| Humans | 202 | 2021 | 930598 | 0.70 | Why? |
| Subcutaneous Tissue | 1 | 2017 | 18 | 0.70 | Why? |
| Benzophenanthridines | 1 | 2017 | 12 | 0.69 | Why? |
| Fluoroscopy | 2 | 2018 | 140 | 0.69 | Why? |
| Antithrombin III | 1 | 2017 | 67 | 0.69 | Why? |
| Acidosis | 1 | 2019 | 125 | 0.69 | Why? |
| Glycogen Synthase | 1 | 2016 | 1 | 0.69 | Why? |
| Aortic Aneurysm, Thoracic | 2 | 2017 | 161 | 0.69 | Why? |
| Albuterol | 1 | 2018 | 105 | 0.69 | Why? |
| Activating Transcription Factor 6 | 1 | 2017 | 34 | 0.68 | Why? |
| Hydrocephalus | 1 | 2018 | 139 | 0.68 | Why? |
| Oxidative Stress | 4 | 2019 | 2050 | 0.68 | Why? |
| Vitamin B 12 | 1 | 2018 | 132 | 0.68 | Why? |
| Protein Kinases | 1 | 2017 | 93 | 0.67 | Why? |
| Raloxifene Hydrochloride | 1 | 2017 | 91 | 0.67 | Why? |
| Morphine | 1 | 2017 | 71 | 0.67 | Why? |
| Liver Cirrhosis | 2 | 2019 | 1810 | 0.67 | Why? |
| Diet | 3 | 2019 | 2052 | 0.67 | Why? |
| Chickens | 3 | 2017 | 1010 | 0.66 | Why? |
| Down-Regulation | 4 | 2019 | 1416 | 0.66 | Why? |
| Amino Acids | 1 | 2021 | 552 | 0.66 | Why? |
| Ventricular Function, Left | 4 | 2021 | 1555 | 0.66 | Why? |
| Ginsenosides | 1 | 2017 | 55 | 0.66 | Why? |
| Myocardium | 7 | 2019 | 2323 | 0.66 | Why? |
| Penile Erection | 1 | 2017 | 58 | 0.65 | Why? |
| China | 43 | 2021 | 50654 | 0.65 | Why? |
| Growth Disorders | 1 | 2017 | 91 | 0.65 | Why? |
| Vesicular Transport Proteins | 1 | 2017 | 110 | 0.65 | Why? |
| Pharmacogenomic Variants | 1 | 2017 | 112 | 0.65 | Why? |
| Mother-Child Relations | 2 | 2017 | 148 | 0.65 | Why? |
| Protein C | 1 | 2017 | 141 | 0.65 | Why? |
| Isoquinolines | 1 | 2017 | 69 | 0.65 | Why? |
| Equipment Failure | 1 | 2018 | 197 | 0.65 | Why? |
| Pacemaker, Artificial | 2 | 2018 | 431 | 0.64 | Why? |
| Gastrointestinal Stromal Tumors | 1 | 2017 | 84 | 0.64 | Why? |
| Tumor Necrosis Factor-alpha | 5 | 2019 | 2483 | 0.64 | Why? |
| Cell Adhesion Molecules | 2 | 2019 | 472 | 0.64 | Why? |
| Accidents, Home | 1 | 2017 | 51 | 0.63 | Why? |
| Neoplasm Proteins | 3 | 2018 | 501 | 0.63 | Why? |
| Nerve Tissue Proteins | 2 | 2018 | 319 | 0.63 | Why? |
| Carcinogenesis | 1 | 2018 | 236 | 0.63 | Why? |
| Platelet Adhesiveness | 1 | 2015 | 19 | 0.63 | Why? |
| Lipoproteins, LDL | 1 | 2017 | 115 | 0.63 | Why? |
| Heme Oxygenase-1 | 1 | 2017 | 90 | 0.63 | Why? |
| DNA-Binding Proteins | 3 | 2018 | 469 | 0.62 | Why? |
| Chemokine CCL2 | 1 | 2018 | 389 | 0.62 | Why? |
| Adrenergic beta-2 Receptor Agonists | 1 | 2018 | 142 | 0.62 | Why? |
| Hypertension, Pregnancy-Induced | 1 | 2018 | 208 | 0.62 | Why? |
| Lactation | 1 | 2019 | 361 | 0.62 | Why? |
| Virulence Factors | 1 | 2019 | 338 | 0.62 | Why? |
| Fires | 1 | 2017 | 87 | 0.61 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 245 | 0.61 | Why? |
| Apolipoprotein A-I | 1 | 2017 | 148 | 0.61 | Why? |
| Up-Regulation | 6 | 2019 | 2249 | 0.61 | Why? |
| Interleukin-6 | 7 | 2020 | 7522 | 0.61 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2018 | 385 | 0.61 | Why? |
| Hodgkin Disease | 1 | 2018 | 204 | 0.60 | Why? |
| Postmenopause | 1 | 2017 | 160 | 0.60 | Why? |
| Pedigree | 9 | 2018 | 502 | 0.60 | Why? |
| Toll-Like Receptor 4 | 1 | 2019 | 390 | 0.60 | Why? |
| Ventricular Dysfunction, Left | 3 | 2021 | 993 | 0.60 | Why? |
| Linguistics | 1 | 2015 | 50 | 0.60 | Why? |
| RNA, Messenger | 9 | 2019 | 5131 | 0.60 | Why? |
| Blood Coagulation Factors | 1 | 2017 | 223 | 0.59 | Why? |
| Genome-Wide Association Study | 4 | 2018 | 1648 | 0.59 | Why? |
| Education | 1 | 2020 | 434 | 0.59 | Why? |
| Neurons | 4 | 2017 | 864 | 0.58 | Why? |
| Aspirin | 2 | 2020 | 1043 | 0.58 | Why? |
| Vasodilator Agents | 1 | 2018 | 344 | 0.58 | Why? |
| Recombinant Fusion Proteins | 3 | 2017 | 919 | 0.58 | Why? |
| Cell Differentiation | 3 | 2017 | 1338 | 0.58 | Why? |
| Vascular Stiffness | 1 | 2018 | 264 | 0.58 | Why? |
| Adipose Tissue | 2 | 2018 | 612 | 0.58 | Why? |
| Feeding Behavior | 4 | 2017 | 1909 | 0.58 | Why? |
| Nanotubes | 1 | 2015 | 72 | 0.58 | Why? |
| Choice Behavior | 1 | 2019 | 319 | 0.57 | Why? |
| Cardiomyopathy, Dilated | 1 | 2018 | 251 | 0.57 | Why? |
| Troponin I | 2 | 2020 | 1298 | 0.57 | Why? |
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2014 | 8 | 0.56 | Why? |
| Polymorphism, Genetic | 4 | 2019 | 1074 | 0.56 | Why? |
| Gene Editing | 4 | 2019 | 330 | 0.55 | Why? |
| Interferon Regulatory Factor-3 | 1 | 2017 | 379 | 0.55 | Why? |
| Cardiomegaly | 4 | 2018 | 96 | 0.55 | Why? |
| Poisoning | 1 | 2017 | 176 | 0.55 | Why? |
| Mutation | 11 | 2019 | 12376 | 0.54 | Why? |
| Neuroprotective Agents | 1 | 2017 | 240 | 0.54 | Why? |
| Automation | 2 | 2017 | 429 | 0.54 | Why? |
| Rural Population | 7 | 2019 | 2408 | 0.54 | Why? |
| Obesity | 6 | 2018 | 7388 | 0.54 | Why? |
| Autophagy | 2 | 2018 | 960 | 0.54 | Why? |
| Coronary Disease | 1 | 2020 | 645 | 0.53 | Why? |
| Protective Agents | 1 | 2017 | 250 | 0.53 | Why? |
| Heart | 3 | 2019 | 1791 | 0.53 | Why? |
| Base Sequence | 7 | 2018 | 3581 | 0.53 | Why? |
| Glycoproteins | 1 | 2019 | 615 | 0.53 | Why? |
| Tobacco Use | 1 | 2017 | 340 | 0.53 | Why? |
| Ventricular Remodeling | 1 | 2017 | 349 | 0.52 | Why? |
| Hepatitis B | 2 | 2019 | 888 | 0.52 | Why? |
| Diet, High-Fat | 4 | 2018 | 161 | 0.52 | Why? |
| Sexual Partners | 1 | 2019 | 612 | 0.52 | Why? |
| Cell Line, Tumor | 13 | 2019 | 3608 | 0.52 | Why? |
| Titanium | 1 | 2015 | 175 | 0.52 | Why? |
| Glucose | 5 | 2018 | 573 | 0.51 | Why? |
| Child Nutrition Sciences | 1 | 2012 | 7 | 0.51 | Why? |
| Mothers | 4 | 2018 | 1624 | 0.51 | Why? |
| Heart Injuries | 1 | 2020 | 608 | 0.51 | Why? |
| Antifungal Agents | 5 | 2018 | 1828 | 0.51 | Why? |
| Gene Regulatory Networks | 3 | 2019 | 820 | 0.51 | Why? |
| Neovascularization, Pathologic | 1 | 2017 | 305 | 0.50 | Why? |
| Central Nervous System Diseases | 1 | 2018 | 410 | 0.50 | Why? |
| AMP-Activated Protein Kinases | 3 | 2019 | 93 | 0.50 | Why? |
| Infant Food | 1 | 2012 | 39 | 0.50 | Why? |
| Fibroblasts | 4 | 2018 | 839 | 0.50 | Why? |
| Weaning | 1 | 2012 | 46 | 0.50 | Why? |
| Diabetic Nephropathies | 1 | 2017 | 315 | 0.50 | Why? |
| Gene Expression Regulation, Plant | 3 | 2017 | 110 | 0.50 | Why? |
| Transcription Factors | 3 | 2018 | 784 | 0.49 | Why? |
| Middle Aged | 65 | 2021 | 270681 | 0.49 | Why? |
| Phosphorylation | 9 | 2019 | 1060 | 0.49 | Why? |
| Glycated Hemoglobin A | 1 | 2021 | 1316 | 0.49 | Why? |
| Aneurysm, Dissecting | 1 | 2017 | 303 | 0.49 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2017 | 604 | 0.49 | Why? |
| Coronary Vessels | 3 | 2018 | 914 | 0.48 | Why? |
| Bronchodilator Agents | 1 | 2018 | 444 | 0.48 | Why? |
| Human Umbilical Vein Endothelial Cells | 5 | 2018 | 286 | 0.48 | Why? |
| Drug Carriers | 1 | 2018 | 590 | 0.48 | Why? |
| Accidental Falls | 1 | 2017 | 448 | 0.48 | Why? |
| Catheter Ablation | 1 | 2017 | 438 | 0.47 | Why? |
| Mouth | 1 | 2017 | 622 | 0.47 | Why? |
| Cytochrome P-450 CYP11B2 | 1 | 2011 | 6 | 0.46 | Why? |
| Neoplasm Invasiveness | 6 | 2019 | 582 | 0.46 | Why? |
| Blood Platelets | 3 | 2019 | 1704 | 0.46 | Why? |
| Hepatitis B virus | 1 | 2019 | 882 | 0.45 | Why? |
| Mice, Knockout | 6 | 2018 | 1815 | 0.45 | Why? |
| Alzheimer Disease | 2 | 2018 | 1020 | 0.45 | Why? |
| Aged | 52 | 2021 | 215776 | 0.45 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.44 | Why? |
| Plants | 3 | 2018 | 247 | 0.44 | Why? |
| Diabetes Mellitus | 5 | 2021 | 8207 | 0.43 | Why? |
| Iron | 1 | 2017 | 619 | 0.43 | Why? |
| Medicine, Chinese Traditional | 2 | 2021 | 2255 | 0.43 | Why? |
| Antihypertensive Agents | 2 | 2020 | 1962 | 0.43 | Why? |
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 441 | 0.42 | Why? |
| Celiac Disease | 1 | 2017 | 471 | 0.42 | Why? |
| Pancreatic Neoplasms | 1 | 2017 | 609 | 0.41 | Why? |
| Transcription, Genetic | 1 | 2016 | 1326 | 0.41 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 4 | 2020 | 5277 | 0.41 | Why? |
| Leukocytes | 1 | 2017 | 1046 | 0.41 | Why? |
| Minority Groups | 2 | 2018 | 1631 | 0.41 | Why? |
| Cardiovascular Diseases | 6 | 2020 | 11497 | 0.41 | Why? |
| Echocardiography | 3 | 2021 | 3661 | 0.41 | Why? |
| Hep G2 Cells | 4 | 2018 | 391 | 0.40 | Why? |
| Genetic Variation | 5 | 2019 | 3919 | 0.39 | Why? |
| Bacterial Proteins | 2 | 2018 | 1318 | 0.39 | Why? |
| Adult | 57 | 2021 | 244371 | 0.39 | Why? |
| Sexual Behavior | 1 | 2019 | 1322 | 0.39 | Why? |
| Cyclic GMP | 3 | 2019 | 50 | 0.38 | Why? |
| Cyclic AMP | 3 | 2017 | 76 | 0.37 | Why? |
| Blotting, Western | 4 | 2018 | 863 | 0.37 | Why? |
| Blood Coagulation | 3 | 2021 | 2768 | 0.37 | Why? |
| Vitamin D3 24-Hydroxylase | 2 | 2018 | 13 | 0.37 | Why? |
| Fibrosis | 5 | 2019 | 800 | 0.37 | Why? |
| Case-Control Studies | 13 | 2020 | 17671 | 0.37 | Why? |
| Prognosis | 19 | 2020 | 32490 | 0.37 | Why? |
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2017 | 96 | 0.37 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.36 | Why? |
| Percutaneous Coronary Intervention | 4 | 2019 | 3646 | 0.36 | Why? |
| Transcriptome | 6 | 2019 | 3466 | 0.36 | Why? |
| Animals, Newborn | 3 | 2018 | 350 | 0.36 | Why? |
| Dependovirus | 3 | 2018 | 272 | 0.36 | Why? |
| Risk Factors | 25 | 2021 | 71621 | 0.35 | Why? |
| Receptors, Calcitriol | 2 | 2019 | 102 | 0.35 | Why? |
| Heart Defects, Congenital | 1 | 2017 | 933 | 0.35 | Why? |
| Gene Knockdown Techniques | 3 | 2019 | 347 | 0.35 | Why? |
| rho-Associated Kinases | 2 | 2017 | 32 | 0.35 | Why? |
| Health Education | 2 | 2017 | 1539 | 0.35 | Why? |
| Malnutrition | 1 | 2017 | 932 | 0.35 | Why? |
| Documentation | 5 | 2018 | 332 | 0.35 | Why? |
| Genetic Loci | 3 | 2018 | 439 | 0.35 | Why? |
| Hypertension | 6 | 2020 | 8895 | 0.35 | Why? |
| Preoperative Care | 1 | 2017 | 1515 | 0.34 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.34 | Why? |
| Kidney Diseases | 1 | 2018 | 1434 | 0.34 | Why? |
| Analgesics, Opioid | 1 | 2017 | 1070 | 0.34 | Why? |
| Evolution, Molecular | 3 | 2018 | 3691 | 0.34 | Why? |
| 3' Untranslated Regions | 2 | 2018 | 318 | 0.34 | Why? |
| Alternative Splicing | 2 | 2017 | 82 | 0.33 | Why? |
| Occupations | 3 | 2018 | 733 | 0.33 | Why? |
| SARS Virus | 3 | 2020 | 13021 | 0.33 | Why? |
| Renin-Angiotensin System | 3 | 2020 | 3661 | 0.33 | Why? |
| Schizophrenia | 1 | 2017 | 1018 | 0.33 | Why? |
| Gene Transfer Techniques | 2 | 2018 | 134 | 0.33 | Why? |
| Angiotensin Receptor Antagonists | 2 | 2020 | 3892 | 0.33 | Why? |
| Cell Line | 12 | 2019 | 12040 | 0.33 | Why? |
| Depressive Disorder | 1 | 2017 | 1236 | 0.32 | Why? |
| Karyotyping | 4 | 2018 | 52 | 0.32 | Why? |
| Aging | 3 | 2019 | 3581 | 0.32 | Why? |
| Haplotypes | 4 | 2018 | 853 | 0.32 | Why? |
| Plasmids | 3 | 2018 | 840 | 0.31 | Why? |
| Acute Coronary Syndrome | 2 | 2017 | 2107 | 0.31 | Why? |
| STAT3 Transcription Factor | 2 | 2018 | 268 | 0.31 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.31 | Why? |
| Parkinson Disease | 1 | 2018 | 1414 | 0.31 | Why? |
| Proteomics | 4 | 2018 | 2481 | 0.31 | Why? |
| Sequence Alignment | 3 | 2018 | 2109 | 0.31 | Why? |
| Vancomycin | 1 | 2009 | 328 | 0.31 | Why? |
| Cytokines | 5 | 2020 | 15010 | 0.31 | Why? |
| Phenotype | 6 | 2019 | 4037 | 0.30 | Why? |
| Wnt Signaling Pathway | 2 | 2018 | 87 | 0.30 | Why? |
| Heparin | 1 | 2019 | 2600 | 0.30 | Why? |
| Carotid Arteries | 3 | 2019 | 182 | 0.30 | Why? |
| Retrospective Studies | 22 | 2021 | 105322 | 0.30 | Why? |
| Microscopy, Electron, Scanning | 2 | 2017 | 221 | 0.30 | Why? |
| Sepsis | 3 | 2020 | 3517 | 0.29 | Why? |
| Sequence Deletion | 3 | 2018 | 674 | 0.29 | Why? |
| Cardiac Surgical Procedures | 1 | 2019 | 1931 | 0.29 | Why? |
| Premature Birth | 1 | 2017 | 2151 | 0.29 | Why? |
| Purinergic P2Y Receptor Antagonists | 2 | 2017 | 206 | 0.29 | Why? |
| Genetic Association Studies | 5 | 2018 | 559 | 0.28 | Why? |
| Phosphatidylinositol 3-Kinases | 2 | 2017 | 347 | 0.28 | Why? |
| Pregnancy | 19 | 2018 | 23879 | 0.28 | Why? |
| Substance-Related Disorders | 2 | 2017 | 2038 | 0.28 | Why? |
| Disease Models, Animal | 13 | 2020 | 10998 | 0.28 | Why? |
| Isoproterenol | 3 | 2018 | 31 | 0.28 | Why? |
| Liver Diseases | 1 | 2020 | 2698 | 0.27 | Why? |
| 8,11,14-Eicosatrienoic Acid | 2 | 2018 | 5 | 0.27 | Why? |
| Epitopes | 1 | 2017 | 4113 | 0.27 | Why? |
| Kidney | 1 | 2018 | 3648 | 0.27 | Why? |
| Nitric Oxide | 4 | 2019 | 769 | 0.27 | Why? |
| Patient Admission | 2 | 2020 | 5250 | 0.27 | Why? |
| Protein Biosynthesis | 2 | 2018 | 653 | 0.27 | Why? |
| DNA Mutational Analysis | 2 | 2019 | 581 | 0.27 | Why? |
| Microvessels | 2 | 2018 | 490 | 0.27 | Why? |
| Mice, Inbred BALB C | 7 | 2019 | 5814 | 0.27 | Why? |
| Parents | 2 | 2017 | 2758 | 0.27 | Why? |
| Plant Diseases | 3 | 2019 | 84 | 0.26 | Why? |
| Lipopolysaccharides | 2 | 2018 | 848 | 0.26 | Why? |
| Disease Management | 3 | 2020 | 6841 | 0.26 | Why? |
| Infant, Premature | 3 | 2017 | 883 | 0.26 | Why? |
| Blood-Brain Barrier | 2 | 2018 | 531 | 0.26 | Why? |
| Hypoxia | 1 | 2019 | 3626 | 0.26 | Why? |
| Histone Deacetylase Inhibitors | 2 | 2017 | 79 | 0.26 | Why? |
| Receptors, G-Protein-Coupled | 2 | 2017 | 309 | 0.26 | Why? |
| Fungi | 2 | 2017 | 471 | 0.26 | Why? |
| Oxidation-Reduction | 2 | 2017 | 540 | 0.26 | Why? |
| Nutrition Assessment | 2 | 2017 | 527 | 0.26 | Why? |
| Host-Pathogen Interactions | 4 | 2021 | 11041 | 0.25 | Why? |
| Cyclooxygenase 2 | 3 | 2019 | 129 | 0.25 | Why? |
| Arrhythmias, Cardiac | 1 | 2017 | 2510 | 0.25 | Why? |
| Calcium | 2 | 2018 | 708 | 0.24 | Why? |
| Neutrophils | 2 | 2020 | 5476 | 0.24 | Why? |
| Coronavirus Infections | 14 | 2020 | 253789 | 0.24 | Why? |
| Amino Acid Sequence | 5 | 2019 | 6049 | 0.24 | Why? |
| Treatment Outcome | 14 | 2021 | 51732 | 0.24 | Why? |
| Rats, Sprague-Dawley | 4 | 2019 | 987 | 0.24 | Why? |
| Cecum | 2 | 2020 | 63 | 0.24 | Why? |
| Biomarkers | 10 | 2021 | 23361 | 0.23 | Why? |
| Gene Expression | 5 | 2019 | 3332 | 0.23 | Why? |
| Dexamethasone | 3 | 2018 | 2055 | 0.23 | Why? |
| Protein Multimerization | 2 | 2019 | 1336 | 0.23 | Why? |
| Caregivers | 2 | 2017 | 3112 | 0.23 | Why? |
| Drug Resistance, Fungal | 3 | 2018 | 191 | 0.23 | Why? |
| Base Pairing | 2 | 2018 | 73 | 0.23 | Why? |
| Stroke | 4 | 2018 | 8839 | 0.23 | Why? |
| Tumor Cells, Cultured | 2 | 2018 | 254 | 0.23 | Why? |
| Cyclic AMP-Dependent Protein Kinases | 2 | 2018 | 36 | 0.23 | Why? |
| Healthy Volunteers | 2 | 2018 | 1444 | 0.23 | Why? |
| Cloning, Molecular | 4 | 2019 | 1036 | 0.23 | Why? |
| MAP Kinase Kinase Kinases | 2 | 2018 | 48 | 0.23 | Why? |
| Rats, Transgenic | 2 | 2019 | 10 | 0.23 | Why? |
| Adolescent Behavior | 2 | 2017 | 400 | 0.22 | Why? |
| Plants, Genetically Modified | 2 | 2018 | 84 | 0.22 | Why? |
| Chromosomes, Artificial, Bacterial | 2 | 2018 | 56 | 0.22 | Why? |
| Mice, Nude | 2 | 2019 | 340 | 0.22 | Why? |
| Violence | 2 | 2017 | 534 | 0.22 | Why? |
| Cardiovascular System | 2 | 2020 | 750 | 0.22 | Why? |
| HEK293 Cells | 7 | 2019 | 8394 | 0.22 | Why? |
| Gene Deletion | 3 | 2018 | 430 | 0.22 | Why? |
| Overweight | 2 | 2018 | 916 | 0.22 | Why? |
| Pneumonia, Viral | 13 | 2020 | 243684 | 0.22 | Why? |
| Smad3 Protein | 2 | 2019 | 40 | 0.22 | Why? |
| Anticoagulants | 2 | 2021 | 9563 | 0.22 | Why? |
| Carcinoma, Renal Cell | 2 | 2018 | 545 | 0.22 | Why? |
| Oryza | 2 | 2019 | 86 | 0.22 | Why? |
| Transcriptional Activation | 2 | 2018 | 196 | 0.22 | Why? |
| Adipocytes | 2 | 2019 | 173 | 0.22 | Why? |
| Betacoronavirus | 11 | 2020 | 204454 | 0.22 | Why? |
| Heterozygote | 3 | 2019 | 249 | 0.21 | Why? |
| Mycoses | 2 | 2018 | 589 | 0.21 | Why? |
| Hemoglobins, Abnormal | 1 | 2019 | 6 | 0.21 | Why? |
| Critical Illness | 6 | 2021 | 17281 | 0.21 | Why? |
| Prospective Studies | 12 | 2021 | 43301 | 0.21 | Why? |
| Hysterectomy | 2 | 2018 | 171 | 0.21 | Why? |
| T-Lymphocytes | 1 | 2018 | 6670 | 0.21 | Why? |
| Protein Transport | 2 | 2019 | 487 | 0.20 | Why? |
| Vitamin D Deficiency | 3 | 2018 | 1782 | 0.20 | Why? |
| Biomechanical Phenomena | 2 | 2018 | 291 | 0.20 | Why? |
| Kaplan-Meier Estimate | 6 | 2019 | 4260 | 0.20 | Why? |
| Stroke Volume | 3 | 2019 | 2153 | 0.20 | Why? |
| Fungal Proteins | 2 | 2018 | 133 | 0.20 | Why? |
| Child Abuse | 2 | 2017 | 504 | 0.20 | Why? |
| Rumen | 1 | 2019 | 3 | 0.20 | Why? |
| Calgranulin A | 1 | 2020 | 74 | 0.20 | Why? |
| Diaminopimelic Acid | 1 | 2019 | 7 | 0.20 | Why? |
| Stroke, Lacunar | 1 | 2019 | 20 | 0.20 | Why? |
| In Situ Nick-End Labeling | 1 | 2019 | 39 | 0.20 | Why? |
| Cystathionine gamma-Lyase | 1 | 2019 | 4 | 0.20 | Why? |
| Reptilian Proteins | 1 | 2019 | 4 | 0.20 | Why? |
| ELAV-Like Protein 1 | 1 | 2019 | 2 | 0.20 | Why? |
| Cohort Studies | 11 | 2020 | 36005 | 0.20 | Why? |
| Plant Immunity | 1 | 2019 | 5 | 0.20 | Why? |
| Lizards | 1 | 2019 | 13 | 0.20 | Why? |
| Vasodilation | 2 | 2019 | 258 | 0.20 | Why? |
| Multigene Family | 2 | 2018 | 377 | 0.20 | Why? |
| Receptors, Glucocorticoid | 2 | 2017 | 118 | 0.20 | Why? |
| Calgranulin B | 1 | 2020 | 144 | 0.20 | Why? |
| Adipogenesis | 1 | 2019 | 38 | 0.20 | Why? |
| Host-Parasite Interactions | 1 | 2020 | 112 | 0.20 | Why? |
| Trophoblastic Tumor, Placental Site | 1 | 2018 | 1 | 0.20 | Why? |
| Alveolar Process | 1 | 2018 | 10 | 0.20 | Why? |
| Nitric Oxide Synthase | 1 | 2019 | 37 | 0.20 | Why? |
| Tissue Survival | 1 | 2019 | 20 | 0.20 | Why? |
| Eye Movement Measurements | 1 | 2018 | 10 | 0.20 | Why? |
| Brain-Derived Neurotrophic Factor | 2 | 2017 | 133 | 0.20 | Why? |
| Salicylic Acid | 1 | 2018 | 10 | 0.20 | Why? |
| Hydroxymethylbilane Synthase | 1 | 2018 | 2 | 0.20 | Why? |
| Orthodontic Appliances | 1 | 2018 | 10 | 0.20 | Why? |
| Mice, Obese | 1 | 2018 | 29 | 0.20 | Why? |
| Porphyria, Acute Intermittent | 1 | 2018 | 3 | 0.20 | Why? |
| Hyperoxaluria, Primary | 1 | 2018 | 15 | 0.20 | Why? |
| Nerve Regeneration | 1 | 2019 | 26 | 0.19 | Why? |
| Staphylococcal Infections | 1 | 2009 | 1099 | 0.19 | Why? |
| Adenylate Kinase | 1 | 2018 | 13 | 0.19 | Why? |
| Chemokine CXCL2 | 1 | 2018 | 21 | 0.19 | Why? |
| HeLa Cells | 3 | 2019 | 1303 | 0.19 | Why? |
| Adenine | 2 | 2019 | 463 | 0.19 | Why? |
| Gelsolin | 1 | 2018 | 31 | 0.19 | Why? |
| Ranolazine | 1 | 2018 | 17 | 0.19 | Why? |
| Maleimides | 1 | 2018 | 21 | 0.19 | Why? |
| Cholesteatoma, Middle Ear | 1 | 2019 | 32 | 0.19 | Why? |
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2018 | 4 | 0.19 | Why? |
| Protein Aggregation, Pathological | 1 | 2018 | 36 | 0.19 | Why? |
| Integrin alpha Chains | 1 | 2018 | 7 | 0.19 | Why? |
| Kidney Neoplasms | 2 | 2018 | 832 | 0.19 | Why? |
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2019 | 78 | 0.19 | Why? |
| Hearing Loss, Bilateral | 1 | 2018 | 19 | 0.19 | Why? |
| alpha-Galactosidase | 1 | 2018 | 32 | 0.19 | Why? |
| Stilbenes | 2 | 2018 | 113 | 0.19 | Why? |
| Nuclear Family | 1 | 2018 | 14 | 0.19 | Why? |
| Chemotaxis | 1 | 2018 | 67 | 0.19 | Why? |
| Arsenites | 1 | 2018 | 15 | 0.19 | Why? |
| Ovalbumin | 1 | 2018 | 84 | 0.19 | Why? |
| Aldehyde Dehydrogenase, Mitochondrial | 1 | 2018 | 10 | 0.19 | Why? |
| MAP Kinase Kinase 2 | 1 | 2018 | 4 | 0.19 | Why? |
| Transforming Growth Factor beta1 | 2 | 2019 | 204 | 0.19 | Why? |
| Sp1 Transcription Factor | 1 | 2018 | 33 | 0.19 | Why? |
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 334 | 0.19 | Why? |
| Electroretinography | 1 | 2018 | 26 | 0.19 | Why? |
| Matrix Metalloproteinase 2 | 1 | 2019 | 85 | 0.19 | Why? |
| Metabolic Syndrome | 2 | 2017 | 810 | 0.19 | Why? |
| Ascites | 1 | 2018 | 65 | 0.19 | Why? |
| Gene Frequency | 4 | 2018 | 1210 | 0.19 | Why? |
| Infant | 11 | 2018 | 30274 | 0.19 | Why? |
| Venous Thromboembolism | 1 | 2017 | 4273 | 0.19 | Why? |
| Placenta Accreta | 1 | 2018 | 24 | 0.19 | Why? |
| Polycomb-Group Proteins | 1 | 2018 | 8 | 0.19 | Why? |
| Sp7 Transcription Factor | 1 | 2017 | 3 | 0.19 | Why? |
| Flavanones | 1 | 2020 | 141 | 0.19 | Why? |
| Aflatoxins | 1 | 2018 | 7 | 0.19 | Why? |
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2017 | 1 | 0.19 | Why? |
| Organophosphonates | 1 | 2019 | 85 | 0.19 | Why? |
| Neurosecretory Systems | 1 | 2018 | 48 | 0.19 | Why? |
| Maternal Inheritance | 1 | 2018 | 6 | 0.19 | Why? |
| Gluconeogenesis | 1 | 2018 | 41 | 0.19 | Why? |
| Triglycerides | 2 | 2018 | 478 | 0.19 | Why? |
| MAP Kinase Kinase 1 | 1 | 2018 | 14 | 0.19 | Why? |
| Porphyra | 1 | 2017 | 1 | 0.19 | Why? |
| Core Binding Factor Alpha 1 Subunit | 1 | 2017 | 12 | 0.19 | Why? |
| Receptor, Serotonin, 5-HT2A | 1 | 2017 | 6 | 0.18 | Why? |
| Peptide Fragments | 2 | 2020 | 2075 | 0.18 | Why? |
| Isoflavones | 1 | 2019 | 52 | 0.18 | Why? |
| Genes, Fungal | 1 | 2018 | 21 | 0.18 | Why? |
| Histone Deacetylase 2 | 1 | 2017 | 12 | 0.18 | Why? |
| Cytosine | 1 | 2019 | 92 | 0.18 | Why? |
| Fagopyrum | 1 | 2017 | 1 | 0.18 | Why? |
| Genome, Insect | 1 | 2017 | 5 | 0.18 | Why? |
| Potassium Channels, Inwardly Rectifying | 1 | 2018 | 29 | 0.18 | Why? |
| Receptors, Peptide | 1 | 2018 | 32 | 0.18 | Why? |
| Flagella | 1 | 2017 | 6 | 0.18 | Why? |
| Phylogeny | 7 | 2018 | 13341 | 0.18 | Why? |
| Swine | 2 | 2018 | 3352 | 0.18 | Why? |
| Genome, Mitochondrial | 1 | 2017 | 14 | 0.18 | Why? |
| Animals, Genetically Modified | 1 | 2018 | 230 | 0.18 | Why? |
| Mitochondria, Heart | 1 | 2017 | 37 | 0.18 | Why? |
| Nurses, Pediatric | 1 | 2018 | 35 | 0.18 | Why? |
| Gene Dosage | 1 | 2018 | 101 | 0.18 | Why? |
| Tooth, Supernumerary | 1 | 2017 | 2 | 0.18 | Why? |
| Therapeutic Equivalency | 1 | 2018 | 64 | 0.18 | Why? |
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 502 | 0.18 | Why? |
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2017 | 29 | 0.18 | Why? |
| Platelet Aggregation Inhibitors | 2 | 2019 | 1671 | 0.18 | Why? |
| Aneuploidy | 1 | 2018 | 27 | 0.18 | Why? |
| Seed Storage Proteins | 1 | 2017 | 8 | 0.18 | Why? |
| DNA Damage | 2 | 2018 | 285 | 0.18 | Why? |
| Morphine Derivatives | 1 | 2017 | 3 | 0.18 | Why? |
| Gene Knock-In Techniques | 1 | 2018 | 124 | 0.18 | Why? |
| Thrombospondins | 1 | 2018 | 26 | 0.18 | Why? |
| Raphanus | 1 | 2017 | 1 | 0.18 | Why? |
| Kallikreins | 1 | 2019 | 158 | 0.18 | Why? |
| Femur Head | 1 | 2017 | 18 | 0.18 | Why? |
| Child Nutritional Physiological Phenomena | 1 | 2018 | 40 | 0.18 | Why? |
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 43 | 0.18 | Why? |
| Incisor | 1 | 2017 | 11 | 0.18 | Why? |
| Proliferating Cell Nuclear Antigen | 1 | 2017 | 18 | 0.18 | Why? |
| Microfilament Proteins | 1 | 2017 | 45 | 0.18 | Why? |
| Histone Acetyltransferases | 1 | 2017 | 27 | 0.18 | Why? |
| Adenylyl Cyclases | 1 | 2017 | 9 | 0.18 | Why? |
| Avian Leukosis | 1 | 2017 | 1 | 0.18 | Why? |
| Avian Leukosis Virus | 1 | 2017 | 1 | 0.18 | Why? |
| HSP20 Heat-Shock Proteins | 1 | 2017 | 5 | 0.18 | Why? |
| Marfan Syndrome | 1 | 2017 | 27 | 0.18 | Why? |
| Aspergillus flavus | 1 | 2018 | 51 | 0.18 | Why? |
| Stomach | 1 | 2019 | 141 | 0.18 | Why? |
| Transaminases | 1 | 2018 | 152 | 0.18 | Why? |
| Infant Equipment | 1 | 2017 | 1 | 0.18 | Why? |
| Phenanthrenes | 1 | 2018 | 87 | 0.18 | Why? |
| Dinoprost | 1 | 2018 | 49 | 0.18 | Why? |
| Brain Damage, Chronic | 1 | 2017 | 15 | 0.18 | Why? |
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 28 | 0.18 | Why? |
| Femur Head Necrosis | 1 | 2017 | 25 | 0.18 | Why? |
| Liraglutide | 1 | 2018 | 47 | 0.18 | Why? |
| rhoB GTP-Binding Protein | 1 | 2017 | 2 | 0.18 | Why? |
| Receptors, Mineralocorticoid | 1 | 2017 | 15 | 0.18 | Why? |
| Altitude | 2 | 2019 | 311 | 0.18 | Why? |
| Nasopharyngeal Neoplasms | 1 | 2018 | 64 | 0.18 | Why? |
| Tooth, Impacted | 1 | 2017 | 12 | 0.18 | Why? |
| Delivery, Obstetric | 2 | 2018 | 1292 | 0.18 | Why? |
| Functional Neuroimaging | 1 | 2018 | 86 | 0.18 | Why? |
| Vibrio cholerae | 1 | 2017 | 44 | 0.18 | Why? |
| Hypoglycemic Agents | 3 | 2021 | 2165 | 0.18 | Why? |
| Isoenzymes | 1 | 2017 | 127 | 0.18 | Why? |
| Cystadenocarcinoma, Serous | 1 | 2017 | 18 | 0.18 | Why? |
| Receptors, Somatomedin | 1 | 2017 | 7 | 0.18 | Why? |
| Pregnancy Complications, Neoplastic | 1 | 2018 | 79 | 0.18 | Why? |
| Child Restraint Systems | 1 | 2017 | 6 | 0.18 | Why? |
| Literacy | 1 | 2017 | 53 | 0.18 | Why? |
| Receptors, Tumor Necrosis Factor | 1 | 2017 | 40 | 0.18 | Why? |
| Avian Proteins | 1 | 2017 | 15 | 0.18 | Why? |
| Exons | 2 | 2018 | 158 | 0.17 | Why? |
| Nitric Oxide Synthase Type I | 1 | 2017 | 5 | 0.17 | Why? |
| Thromboplastin | 1 | 2020 | 275 | 0.17 | Why? |
| Waist-Hip Ratio | 1 | 2017 | 50 | 0.17 | Why? |
| Therapeutic Irrigation | 1 | 2019 | 167 | 0.17 | Why? |
| Bone Development | 1 | 2017 | 8 | 0.17 | Why? |
| Uterine Neoplasms | 1 | 2018 | 70 | 0.17 | Why? |
| DNA, Plant | 1 | 2017 | 14 | 0.17 | Why? |
| Permeability | 1 | 2018 | 238 | 0.17 | Why? |
| Young Adult | 20 | 2019 | 93724 | 0.17 | Why? |
| Hydrogen Sulfide | 1 | 2019 | 86 | 0.17 | Why? |
| Immunoprecipitation | 1 | 2018 | 300 | 0.17 | Why? |
| Varicocele | 1 | 2017 | 11 | 0.17 | Why? |
| Rape | 1 | 2017 | 35 | 0.17 | Why? |
| rhoA GTP-Binding Protein | 1 | 2017 | 24 | 0.17 | Why? |
| Electrophoresis, Gel, Two-Dimensional | 1 | 2017 | 40 | 0.17 | Why? |
| Adamantane | 1 | 2018 | 68 | 0.17 | Why? |
| Cryosurgery | 1 | 2018 | 57 | 0.17 | Why? |
| cdc25 Phosphatases | 1 | 2016 | 5 | 0.17 | Why? |
| Protein Kinase C | 1 | 2017 | 58 | 0.17 | Why? |
| Evoked Potentials | 1 | 2017 | 44 | 0.17 | Why? |
| Receptor, Notch4 | 1 | 2017 | 35 | 0.17 | Why? |
| Radiotherapy, Intensity-Modulated | 1 | 2018 | 148 | 0.17 | Why? |
| Heat Shock Transcription Factors | 1 | 2017 | 11 | 0.17 | Why? |
| Paraganglioma | 1 | 2017 | 33 | 0.17 | Why? |
| Lamivudine | 1 | 2019 | 210 | 0.17 | Why? |
| Protein Processing, Post-Translational | 2 | 2019 | 634 | 0.17 | Why? |
| Pulse Wave Analysis | 1 | 2018 | 221 | 0.17 | Why? |
| Melanoma, Experimental | 1 | 2017 | 57 | 0.17 | Why? |
| Blood Pressure | 2 | 2019 | 2198 | 0.17 | Why? |
| Snail Family Transcription Factors | 1 | 2017 | 20 | 0.17 | Why? |
| Personnel Turnover | 1 | 2018 | 121 | 0.17 | Why? |
| Infant Formula | 1 | 2018 | 64 | 0.17 | Why? |
| Polycythemia | 1 | 2017 | 19 | 0.17 | Why? |
| Amidohydrolases | 1 | 2017 | 30 | 0.17 | Why? |
| Psychomotor Performance | 1 | 2018 | 110 | 0.17 | Why? |
| Sirtuin 1 | 1 | 2018 | 100 | 0.17 | Why? |
| Radiographic Image Enhancement | 1 | 2017 | 89 | 0.17 | Why? |
| Endothelium, Vascular | 2 | 2019 | 1751 | 0.17 | Why? |
| Stress, Physiological | 2 | 2018 | 378 | 0.17 | Why? |
| Endothelium | 1 | 2021 | 460 | 0.17 | Why? |
| Actins | 1 | 2017 | 108 | 0.17 | Why? |
| Rest | 1 | 2018 | 188 | 0.17 | Why? |
| Membrane Potential, Mitochondrial | 1 | 2017 | 102 | 0.17 | Why? |
| Chimera | 1 | 2017 | 83 | 0.17 | Why? |
| Protein Structure, Quaternary | 1 | 2019 | 455 | 0.17 | Why? |
| Fabry Disease | 1 | 2018 | 106 | 0.17 | Why? |
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2018 | 113 | 0.17 | Why? |
| Otologic Surgical Procedures | 1 | 2019 | 93 | 0.17 | Why? |
| Coculture Techniques | 1 | 2018 | 258 | 0.17 | Why? |
| Ecological Momentary Assessment | 1 | 2018 | 139 | 0.17 | Why? |
| Term Birth | 1 | 2017 | 56 | 0.17 | Why? |
| Pheochromocytoma | 1 | 2017 | 32 | 0.17 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 238 | 0.17 | Why? |
| Dipeptides | 1 | 2018 | 106 | 0.17 | Why? |
| Cell Survival | 3 | 2018 | 1581 | 0.17 | Why? |
| Brain | 4 | 2018 | 5133 | 0.17 | Why? |
| Transcription Factor AP-1 | 1 | 2017 | 75 | 0.17 | Why? |
| Odds Ratio | 3 | 2017 | 5861 | 0.17 | Why? |
| Intramolecular Oxidoreductases | 1 | 2017 | 38 | 0.17 | Why? |
| Immediate-Early Proteins | 1 | 2016 | 44 | 0.17 | Why? |
| Lysophospholipids | 1 | 2017 | 74 | 0.17 | Why? |
| Fetal Heart | 1 | 2017 | 46 | 0.17 | Why? |
| Escherichia coli Proteins | 1 | 2018 | 168 | 0.17 | Why? |
| Arterial Pressure | 1 | 2019 | 208 | 0.17 | Why? |
| Physical Abuse | 1 | 2017 | 78 | 0.17 | Why? |
| Hypogonadism | 1 | 2018 | 196 | 0.17 | Why? |
| Antibodies, Antinuclear | 1 | 2019 | 234 | 0.17 | Why? |
| Abortion, Habitual | 1 | 2017 | 35 | 0.17 | Why? |
| Home Childbirth | 1 | 2017 | 65 | 0.16 | Why? |
| Forkhead Transcription Factors | 1 | 2018 | 231 | 0.16 | Why? |
| Breast Feeding | 2 | 2018 | 1585 | 0.16 | Why? |
| Neural Conduction | 1 | 2018 | 261 | 0.16 | Why? |
| Enterocolitis, Necrotizing | 1 | 2017 | 71 | 0.16 | Why? |
| Anopheles | 1 | 2017 | 89 | 0.16 | Why? |
| Cholesterol, HDL | 1 | 2020 | 439 | 0.16 | Why? |
| INDEL Mutation | 1 | 2017 | 128 | 0.16 | Why? |
| MAP Kinase Signaling System | 2 | 2018 | 360 | 0.16 | Why? |
| Antiviral Agents | 3 | 2020 | 41703 | 0.16 | Why? |
| Anthropometry | 1 | 2017 | 233 | 0.16 | Why? |
| Chick Embryo | 1 | 2017 | 249 | 0.16 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2018 | 393 | 0.16 | Why? |
| Trans-Activators | 1 | 2018 | 170 | 0.16 | Why? |
| Flavonoids | 2 | 2020 | 492 | 0.16 | Why? |
| Alkaline Phosphatase | 1 | 2017 | 257 | 0.16 | Why? |
| Civil Disorders | 1 | 2017 | 60 | 0.16 | Why? |
| Nerve Net | 1 | 2018 | 118 | 0.16 | Why? |
| Sphingosine | 1 | 2017 | 101 | 0.16 | Why? |
| Tetralogy of Fallot | 1 | 2017 | 43 | 0.16 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2018 | 343 | 0.16 | Why? |
| Television | 1 | 2018 | 224 | 0.16 | Why? |
| Cryptococcus neoformans | 1 | 2017 | 71 | 0.16 | Why? |
| Child Behavior Disorders | 1 | 2017 | 107 | 0.16 | Why? |
| Cell Hypoxia | 1 | 2017 | 141 | 0.16 | Why? |
| Loss of Function Mutation | 1 | 2018 | 244 | 0.16 | Why? |
| Genes, Reporter | 1 | 2018 | 472 | 0.16 | Why? |
| Dental Etching | 1 | 2015 | 1 | 0.16 | Why? |
| Dental Polishing | 1 | 2015 | 1 | 0.16 | Why? |
| Sodium | 1 | 2018 | 309 | 0.16 | Why? |
| Drug Resistance | 1 | 2019 | 395 | 0.16 | Why? |
| Adrenal Gland Neoplasms | 1 | 2017 | 70 | 0.16 | Why? |
| Waist Circumference | 1 | 2017 | 199 | 0.16 | Why? |
| Thrombosis | 1 | 2019 | 7504 | 0.16 | Why? |
| Catheterization | 1 | 2019 | 264 | 0.16 | Why? |
| Memory, Short-Term | 1 | 2017 | 137 | 0.16 | Why? |
| Linear Models | 3 | 2017 | 1914 | 0.16 | Why? |
| Microbial Sensitivity Tests | 4 | 2019 | 2886 | 0.16 | Why? |
| Biological Transport | 1 | 2017 | 290 | 0.16 | Why? |
| Dopamine | 1 | 2017 | 123 | 0.16 | Why? |
| Penis | 1 | 2017 | 101 | 0.16 | Why? |
| Hearing Loss, Sudden | 1 | 2018 | 103 | 0.16 | Why? |
| Gene Silencing | 1 | 2017 | 213 | 0.16 | Why? |
| Diterpenes | 1 | 2018 | 157 | 0.16 | Why? |
| Monocytes | 3 | 2019 | 2978 | 0.16 | Why? |
| Cholesterol, LDL | 1 | 2020 | 499 | 0.16 | Why? |
| Behavior, Animal | 1 | 2017 | 136 | 0.16 | Why? |
| Metals | 1 | 2018 | 182 | 0.16 | Why? |
| Random Allocation | 5 | 2018 | 773 | 0.15 | Why? |
| First Aid | 1 | 2017 | 127 | 0.15 | Why? |
| Dose-Response Relationship, Drug | 3 | 2020 | 3776 | 0.15 | Why? |
| Sequence Homology, Nucleic Acid | 1 | 2017 | 368 | 0.15 | Why? |
| Plant Leaves | 1 | 2017 | 233 | 0.15 | Why? |
| Hepatitis B Vaccines | 1 | 2018 | 245 | 0.15 | Why? |
| Cryptococcosis | 1 | 2017 | 97 | 0.15 | Why? |
| Follow-Up Studies | 7 | 2019 | 17020 | 0.15 | Why? |
| Social Determinants of Health | 2 | 2018 | 1757 | 0.15 | Why? |
| Receptors, Estrogen | 1 | 2017 | 171 | 0.15 | Why? |
| Organ Specificity | 2 | 2017 | 1070 | 0.15 | Why? |
| Mutagenesis, Site-Directed | 1 | 2017 | 449 | 0.15 | Why? |
| Cattle Diseases | 1 | 2019 | 294 | 0.15 | Why? |
| Hearing Loss, Sensorineural | 1 | 2018 | 159 | 0.15 | Why? |
| Infant Care | 1 | 2018 | 178 | 0.15 | Why? |
| Drug Compounding | 1 | 2018 | 386 | 0.15 | Why? |
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 230 | 0.15 | Why? |
| Collagen | 1 | 2017 | 222 | 0.15 | Why? |
| Sequence Analysis, RNA | 4 | 2017 | 2290 | 0.15 | Why? |
| Histocompatibility Antigens Class II | 1 | 2018 | 383 | 0.15 | Why? |
| Maternal Death | 1 | 2017 | 108 | 0.15 | Why? |
| Cattle | 2 | 2019 | 1336 | 0.15 | Why? |
| Nutrition Surveys | 1 | 2017 | 287 | 0.15 | Why? |
| Medical Audit | 1 | 2017 | 218 | 0.15 | Why? |
| Genotyping Techniques | 1 | 2018 | 360 | 0.15 | Why? |
| Glioma | 1 | 2018 | 189 | 0.15 | Why? |
| Carotid Artery Diseases | 1 | 2019 | 251 | 0.15 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 382 | 0.15 | Why? |
| DNA, Mitochondrial | 1 | 2017 | 163 | 0.15 | Why? |
| Earthquakes | 1 | 2018 | 165 | 0.15 | Why? |
| Peptides | 2 | 2018 | 2513 | 0.15 | Why? |
| Pregnancy Complications, Cardiovascular | 1 | 2018 | 231 | 0.15 | Why? |
| Surgery, Computer-Assisted | 1 | 2018 | 183 | 0.15 | Why? |
| RNA Stability | 1 | 2017 | 285 | 0.15 | Why? |
| Executive Function | 1 | 2017 | 173 | 0.15 | Why? |
| Adaptation, Physiological | 1 | 2018 | 359 | 0.15 | Why? |
| Catheterization, Peripheral | 1 | 2019 | 249 | 0.15 | Why? |
| Enterovirus A, Human | 1 | 2017 | 180 | 0.15 | Why? |
| Vocabulary, Controlled | 1 | 2015 | 26 | 0.15 | Why? |
| Prosthesis Implantation | 1 | 2018 | 261 | 0.15 | Why? |
| Genetic Counseling | 1 | 2018 | 229 | 0.15 | Why? |
| Kidney Tubules | 1 | 2017 | 205 | 0.14 | Why? |
| Capsid Proteins | 1 | 2018 | 365 | 0.14 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.14 | Why? |
| Blood Pressure Determination | 1 | 2019 | 450 | 0.14 | Why? |
| Cell Communication | 1 | 2017 | 396 | 0.14 | Why? |
| Janus Kinases | 1 | 2018 | 414 | 0.14 | Why? |
| Erectile Dysfunction | 1 | 2017 | 141 | 0.14 | Why? |
| Mast Cells | 1 | 2018 | 370 | 0.14 | Why? |
| Pain Measurement | 1 | 2018 | 533 | 0.14 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 436 | 0.14 | Why? |
| Facial Paralysis | 1 | 2019 | 231 | 0.14 | Why? |
| Hydrogen-Ion Concentration | 1 | 2019 | 993 | 0.14 | Why? |
| Review Literature as Topic | 1 | 2018 | 387 | 0.14 | Why? |
| Operative Time | 1 | 2017 | 450 | 0.14 | Why? |
| Pattern Recognition, Automated | 1 | 2015 | 160 | 0.14 | Why? |
| Time Factors | 7 | 2021 | 31397 | 0.14 | Why? |
| Prednisolone | 1 | 2018 | 443 | 0.14 | Why? |
| Metabolomics | 1 | 2021 | 921 | 0.14 | Why? |
| Infant, Newborn | 9 | 2018 | 23105 | 0.14 | Why? |
| Phagocytosis | 2 | 2020 | 409 | 0.14 | Why? |
| Comorbidity | 6 | 2021 | 34796 | 0.14 | Why? |
| Nutritional Status | 2 | 2017 | 1403 | 0.14 | Why? |
| Endoplasmic Reticulum Stress | 1 | 2017 | 253 | 0.14 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.14 | Why? |
| Microsurgery | 1 | 2017 | 166 | 0.14 | Why? |
| Virus Latency | 1 | 2016 | 251 | 0.14 | Why? |
| NF-E2-Related Factor 2 | 1 | 2018 | 373 | 0.14 | Why? |
| Chromatography, Liquid | 1 | 2018 | 640 | 0.14 | Why? |
| Colorectal Neoplasms | 2 | 2019 | 1884 | 0.14 | Why? |
| Surgical Wound Infection | 2 | 2017 | 501 | 0.14 | Why? |
| Thrombotic Microangiopathies | 1 | 2018 | 335 | 0.14 | Why? |
| Health Status | 2 | 2018 | 3259 | 0.14 | Why? |
| Alkaloids | 1 | 2017 | 255 | 0.14 | Why? |
| Sample Size | 1 | 2017 | 518 | 0.14 | Why? |
| Wnt Proteins | 1 | 2014 | 38 | 0.14 | Why? |
| Lab-On-A-Chip Devices | 1 | 2018 | 411 | 0.14 | Why? |
| Aortic Aneurysm, Abdominal | 1 | 2017 | 155 | 0.14 | Why? |
| CRISPR-Associated Proteins | 1 | 2017 | 258 | 0.14 | Why? |
| Proportional Hazards Models | 4 | 2019 | 6543 | 0.14 | Why? |
| Postpartum Period | 2 | 2018 | 936 | 0.14 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2018 | 11367 | 0.14 | Why? |
| Beijing | 1 | 2017 | 912 | 0.14 | Why? |
| beta-Thalassemia | 1 | 2017 | 200 | 0.13 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.13 | Why? |
| Plaque, Atherosclerotic | 1 | 2019 | 423 | 0.13 | Why? |
| Ultrasonography, Prenatal | 1 | 2018 | 471 | 0.13 | Why? |
| Arginine | 1 | 2017 | 377 | 0.13 | Why? |
| Pancreas | 1 | 2017 | 398 | 0.13 | Why? |
| Surface Properties | 1 | 2015 | 448 | 0.13 | Why? |
| Epoxy Compounds | 2 | 2018 | 21 | 0.13 | Why? |
| Nuclear Proteins | 1 | 2016 | 321 | 0.13 | Why? |
| Genetic Therapy | 1 | 2018 | 409 | 0.13 | Why? |
| Parturition | 1 | 2018 | 514 | 0.13 | Why? |
| Hematoma | 1 | 2017 | 305 | 0.13 | Why? |
| Cell Membrane | 1 | 2019 | 743 | 0.13 | Why? |
| Microglia | 1 | 2017 | 357 | 0.13 | Why? |
| Body Weight | 2 | 2018 | 1074 | 0.13 | Why? |
| Cognition | 3 | 2018 | 1394 | 0.13 | Why? |
| Complement C3d | 1 | 2013 | 17 | 0.13 | Why? |
| Blood Coagulation Tests | 1 | 2019 | 855 | 0.13 | Why? |
| Regeneration | 1 | 2017 | 429 | 0.13 | Why? |
| Interleukin-1beta | 1 | 2019 | 992 | 0.13 | Why? |
| Area Under Curve | 2 | 2019 | 2564 | 0.13 | Why? |
| Cesarean Section | 3 | 2018 | 2089 | 0.13 | Why? |
| Cannula | 1 | 2019 | 750 | 0.13 | Why? |
| Myocardial Infarction | 2 | 2020 | 3361 | 0.13 | Why? |
| Metabolome | 1 | 2018 | 624 | 0.13 | Why? |
| Platelet Activation | 1 | 2017 | 660 | 0.13 | Why? |
| Dipeptidyl Peptidase 4 | 1 | 2020 | 1061 | 0.13 | Why? |
| Multimodal Imaging | 1 | 2017 | 534 | 0.13 | Why? |
| Indoles | 2 | 2018 | 1243 | 0.13 | Why? |
| Risk | 4 | 2019 | 5288 | 0.13 | Why? |
| Influenzavirus A | 1 | 2013 | 66 | 0.12 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2017 | 691 | 0.12 | Why? |
| Pharmacy | 1 | 2018 | 326 | 0.12 | Why? |
| Diabetic Retinopathy | 1 | 2018 | 347 | 0.12 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.12 | Why? |
| Immune Tolerance | 1 | 2018 | 608 | 0.12 | Why? |
| Shock, Septic | 2 | 2020 | 1313 | 0.12 | Why? |
| Maternal Mortality | 1 | 2017 | 461 | 0.12 | Why? |
| Wound Healing | 1 | 2017 | 424 | 0.12 | Why? |
| Antigens, CD | 1 | 2018 | 984 | 0.12 | Why? |
| Mass Spectrometry | 1 | 2018 | 1165 | 0.12 | Why? |
| Protective Devices | 1 | 2017 | 493 | 0.12 | Why? |
| Maternal Health | 1 | 2017 | 331 | 0.12 | Why? |
| Medical History Taking | 1 | 2014 | 350 | 0.12 | Why? |
| Patient Reported Outcome Measures | 1 | 2018 | 912 | 0.12 | Why? |
| Multivariate Analysis | 3 | 2019 | 5440 | 0.12 | Why? |
| Cardiovascular Agents | 1 | 2018 | 663 | 0.12 | Why? |
| Immunophenotyping | 1 | 2017 | 1290 | 0.12 | Why? |
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2017 | 624 | 0.12 | Why? |
| Molecular Sequence Data | 2 | 2017 | 3198 | 0.12 | Why? |
| Infertility, Male | 1 | 2017 | 322 | 0.12 | Why? |
| Tandem Mass Spectrometry | 1 | 2018 | 1031 | 0.12 | Why? |
| Gestational Age | 1 | 2017 | 1488 | 0.12 | Why? |
| Eosinophils | 1 | 2018 | 848 | 0.12 | Why? |
| alpha-2-HS-Glycoprotein | 1 | 2011 | 25 | 0.12 | Why? |
| Molecular Targeted Therapy | 2 | 2019 | 1579 | 0.12 | Why? |
| Mutation, Missense | 2 | 2017 | 863 | 0.11 | Why? |
| Heart Ventricles | 2 | 2018 | 1139 | 0.11 | Why? |
| Intracranial Arterial Diseases | 1 | 2010 | 9 | 0.11 | Why? |
| Neuropsychological Tests | 1 | 2017 | 954 | 0.11 | Why? |
| Phosphoproteins | 2 | 2019 | 4346 | 0.11 | Why? |
| Diagnostic Errors | 1 | 2018 | 865 | 0.11 | Why? |
| Diabetes, Gestational | 1 | 2017 | 426 | 0.11 | Why? |
| Phytotherapy | 1 | 2019 | 743 | 0.11 | Why? |
| Pneumonia, Bacterial | 1 | 2019 | 843 | 0.11 | Why? |
| Ovarian Neoplasms | 1 | 2017 | 465 | 0.11 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.11 | Why? |
| Parenting | 1 | 2017 | 486 | 0.11 | Why? |
| Stress, Psychological | 4 | 2018 | 10231 | 0.11 | Why? |
| Contrast Media | 1 | 2017 | 1011 | 0.11 | Why? |
| Rhinitis, Allergic | 1 | 2018 | 704 | 0.11 | Why? |
| Cytomegalovirus | 1 | 2016 | 600 | 0.11 | Why? |
| Biological Evolution | 1 | 2017 | 641 | 0.11 | Why? |
| Stress Disorders, Post-Traumatic | 2 | 2018 | 2963 | 0.11 | Why? |
| Open Reading Frames | 1 | 2018 | 1898 | 0.11 | Why? |
| Reproducibility of Results | 5 | 2018 | 11304 | 0.11 | Why? |
| Feasibility Studies | 2 | 2017 | 3467 | 0.11 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 877 | 0.11 | Why? |
| Cytochrome P-450 CYP4A | 1 | 2010 | 4 | 0.11 | Why? |
| Cytochrome P450 Family 4 | 1 | 2010 | 7 | 0.11 | Why? |
| Bronchopulmonary Dysplasia | 1 | 2011 | 53 | 0.11 | Why? |
| Brain Neoplasms | 1 | 2018 | 669 | 0.11 | Why? |
| Interferon-beta | 1 | 2017 | 979 | 0.11 | Why? |
| Sex Factors | 4 | 2018 | 11014 | 0.11 | Why? |
| Cross-Sectional Studies | 10 | 2021 | 53120 | 0.11 | Why? |
| Peptide Hydrolases | 1 | 2018 | 1269 | 0.11 | Why? |
| Interleukin-10 | 2 | 2017 | 1409 | 0.11 | Why? |
| Neuraminidase | 1 | 2013 | 289 | 0.11 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 1115 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Atherosclerosis | 1 | 2019 | 768 | 0.11 | Why? |
| Antibodies | 1 | 2017 | 846 | 0.11 | Why? |
| Drug Interactions | 1 | 2018 | 1653 | 0.11 | Why? |
| Constriction, Pathologic | 3 | 2017 | 212 | 0.10 | Why? |
| L-Lactate Dehydrogenase | 1 | 2019 | 1995 | 0.10 | Why? |
| Disease Progression | 6 | 2019 | 13580 | 0.10 | Why? |
| Gastrointestinal Tract | 1 | 2019 | 1113 | 0.10 | Why? |
| Coronary Artery Bypass | 1 | 2017 | 629 | 0.10 | Why? |
| RNA Interference | 3 | 2018 | 534 | 0.10 | Why? |
| Suicide, Attempted | 1 | 2017 | 599 | 0.10 | Why? |
| Tomography, Optical Coherence | 1 | 2018 | 1008 | 0.10 | Why? |
| Aged, 80 and over | 10 | 2021 | 88759 | 0.10 | Why? |
| Hydroxamic Acids | 1 | 2009 | 43 | 0.10 | Why? |
| Respiratory Tract Diseases | 1 | 2018 | 1061 | 0.10 | Why? |
| Acute Disease | 2 | 2020 | 6029 | 0.10 | Why? |
| Housing | 1 | 2018 | 1146 | 0.10 | Why? |
| Migraine Disorders | 1 | 2017 | 530 | 0.10 | Why? |
| Social Behavior | 1 | 2018 | 882 | 0.10 | Why? |
| Drug Monitoring | 1 | 2018 | 1408 | 0.10 | Why? |
| RNA-Binding Proteins | 1 | 2017 | 1022 | 0.10 | Why? |
| Cation Transport Proteins | 1 | 2009 | 53 | 0.10 | Why? |
| Publishing | 1 | 2020 | 990 | 0.10 | Why? |
| Polysaccharides | 1 | 2017 | 854 | 0.10 | Why? |
| Blood Glucose | 3 | 2018 | 3642 | 0.10 | Why? |
| Risk Assessment | 5 | 2021 | 25439 | 0.10 | Why? |
| Medical Informatics | 1 | 2017 | 648 | 0.10 | Why? |
| Pandemics | 14 | 2021 | 389249 | 0.10 | Why? |
| Healthcare Disparities | 2 | 2018 | 3893 | 0.10 | Why? |
| Pain Management | 1 | 2018 | 854 | 0.10 | Why? |
| Receptors, Interleukin-6 | 1 | 2017 | 1383 | 0.10 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.10 | Why? |
| Adolescent | 16 | 2019 | 86841 | 0.10 | Why? |
| ROC Curve | 5 | 2020 | 6024 | 0.10 | Why? |
| Hyaluronan Receptors | 1 | 2009 | 61 | 0.10 | Why? |
| Pain | 1 | 2017 | 1084 | 0.10 | Why? |
| Rats, Inbred WKY | 2 | 2019 | 6 | 0.10 | Why? |
| Diagnostic Imaging | 1 | 2017 | 1044 | 0.10 | Why? |
| Ozone | 1 | 2017 | 757 | 0.09 | Why? |
| Family Health | 1 | 2014 | 731 | 0.09 | Why? |
| Air Pollution | 2 | 2018 | 3504 | 0.09 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.09 | Why? |
| Rats, Inbred SHR | 2 | 2019 | 58 | 0.09 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2018 | 1458 | 0.09 | Why? |
| Synteny | 2 | 2018 | 38 | 0.09 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.09 | Why? |
| Femoral Artery | 1 | 2010 | 213 | 0.09 | Why? |
| Binding Sites | 2 | 2018 | 6201 | 0.09 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1573 | 0.09 | Why? |
| Cluster Analysis | 2 | 2018 | 3001 | 0.09 | Why? |
| Activities of Daily Living | 1 | 2017 | 1530 | 0.09 | Why? |
| Program Evaluation | 1 | 2017 | 1929 | 0.09 | Why? |
| Neoplasm Staging | 4 | 2018 | 1999 | 0.09 | Why? |
| Incidence | 3 | 2019 | 25622 | 0.09 | Why? |
| Predictive Value of Tests | 2 | 2021 | 9537 | 0.09 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.09 | Why? |
| Income | 1 | 2017 | 1564 | 0.09 | Why? |
| Insulin | 1 | 2017 | 1316 | 0.09 | Why? |
| Chromosome Deletion | 2 | 2017 | 62 | 0.09 | Why? |
| Mice, Inbred NOD | 2 | 2018 | 134 | 0.09 | Why? |
| Mice, SCID | 2 | 2018 | 225 | 0.09 | Why? |
| Research | 1 | 2021 | 2115 | 0.09 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.09 | Why? |
| Calcinosis | 1 | 2010 | 240 | 0.09 | Why? |
| Whole Genome Sequencing | 1 | 2019 | 3239 | 0.09 | Why? |
| Ferritins | 1 | 2017 | 2055 | 0.09 | Why? |
| Suicidal Ideation | 1 | 2017 | 1226 | 0.09 | Why? |
| Placenta | 1 | 2018 | 1531 | 0.09 | Why? |
| Survival Analysis | 5 | 2020 | 7592 | 0.09 | Why? |
| Models, Molecular | 2 | 2019 | 7616 | 0.08 | Why? |
| Data Collection | 1 | 2017 | 1769 | 0.08 | Why? |
| Equipment Design | 1 | 2018 | 3095 | 0.08 | Why? |
| Macrophages, Alveolar | 1 | 2011 | 668 | 0.08 | Why? |
| Medication Adherence | 1 | 2017 | 1270 | 0.08 | Why? |
| Immune Evasion | 1 | 2017 | 2081 | 0.08 | Why? |
| Perception | 1 | 2018 | 2827 | 0.08 | Why? |
| Child | 6 | 2018 | 70012 | 0.08 | Why? |
| Survival Rate | 2 | 2018 | 9206 | 0.08 | Why? |
| Gene Knockout Techniques | 2 | 2018 | 347 | 0.08 | Why? |
| Pneumonia, Pneumocystis | 1 | 2011 | 322 | 0.08 | Why? |
| Disease Susceptibility | 1 | 2020 | 4002 | 0.08 | Why? |
| Laryngeal Neoplasms | 1 | 2009 | 202 | 0.08 | Why? |
| Adenoviridae | 1 | 2013 | 1151 | 0.08 | Why? |
| Prenatal Care | 1 | 2017 | 1314 | 0.08 | Why? |
| Surveys and Questionnaires | 6 | 2018 | 43792 | 0.08 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.08 | Why? |
| Liver | 2 | 2018 | 4007 | 0.08 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.08 | Why? |
| Protein Isoforms | 2 | 2017 | 347 | 0.08 | Why? |
| Melanoma | 1 | 2017 | 1229 | 0.08 | Why? |
| Transfection | 3 | 2016 | 864 | 0.08 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 7868 | 0.08 | Why? |
| Socioeconomic Factors | 3 | 2018 | 8495 | 0.08 | Why? |
| Survivors | 1 | 2018 | 2619 | 0.08 | Why? |
| Fatigue | 1 | 2017 | 2479 | 0.08 | Why? |
| Vitamin D | 2 | 2018 | 2904 | 0.07 | Why? |
| Nanoparticles | 1 | 2017 | 2040 | 0.07 | Why? |
| Hygiene | 1 | 2012 | 987 | 0.07 | Why? |
| Neoplasms | 3 | 2018 | 17251 | 0.07 | Why? |
| Oxygen | 2 | 2017 | 3715 | 0.07 | Why? |
| Alcohol Drinking | 1 | 2017 | 1663 | 0.07 | Why? |
| World Health Organization | 1 | 2018 | 4213 | 0.07 | Why? |
| Immunization Programs | 1 | 2018 | 2006 | 0.07 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.07 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 1510 | 0.07 | Why? |
| Blood Coagulation Disorders | 1 | 2019 | 2040 | 0.07 | Why? |
| Adaptation, Psychological | 3 | 2018 | 4996 | 0.07 | Why? |
| Cognitive Dysfunction | 1 | 2016 | 1389 | 0.07 | Why? |
| Logistic Models | 5 | 2018 | 9089 | 0.07 | Why? |
| Particulate Matter | 1 | 2017 | 3249 | 0.07 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.07 | Why? |
| Sequence Analysis, DNA | 3 | 2018 | 2830 | 0.07 | Why? |
| Drugs, Chinese Herbal | 1 | 2020 | 2760 | 0.07 | Why? |
| Neoplasm Metastasis | 2 | 2018 | 682 | 0.07 | Why? |
| Prostatic Neoplasms | 1 | 2017 | 1637 | 0.07 | Why? |
| Aorta | 2 | 2017 | 355 | 0.07 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.07 | Why? |
| Quality Improvement | 1 | 2017 | 2435 | 0.07 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.07 | Why? |
| Occupational Health | 2 | 2018 | 3965 | 0.07 | Why? |
| Skin Neoplasms | 1 | 2017 | 1679 | 0.07 | Why? |
| Lung Neoplasms | 2 | 2018 | 3228 | 0.06 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.06 | Why? |
| RNA, Small Interfering | 2 | 2018 | 817 | 0.06 | Why? |
| Virus Replication | 3 | 2020 | 14331 | 0.06 | Why? |
| Child, Preschool | 5 | 2018 | 36283 | 0.06 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.06 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.06 | Why? |
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 8811 | 0.06 | Why? |
| Sensitivity and Specificity | 3 | 2018 | 22971 | 0.06 | Why? |
| Nurses | 1 | 2018 | 2285 | 0.06 | Why? |
| Drug Discovery | 1 | 2017 | 3092 | 0.06 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.06 | Why? |
| Burnout, Professional | 1 | 2018 | 2489 | 0.06 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.06 | Why? |
| Cell Death | 2 | 2018 | 536 | 0.06 | Why? |
| African Americans | 1 | 2017 | 3363 | 0.06 | Why? |
| Computational Biology | 1 | 2017 | 4514 | 0.06 | Why? |
| Glucocorticoids | 1 | 2017 | 4431 | 0.06 | Why? |
| Models, Theoretical | 2 | 2017 | 6659 | 0.05 | Why? |
| Health Policy | 2 | 2018 | 6242 | 0.05 | Why? |
| Ligation | 1 | 2020 | 84 | 0.05 | Why? |
| Machine Learning | 1 | 2017 | 4395 | 0.05 | Why? |
| Mesenteric Arteries | 1 | 2019 | 22 | 0.05 | Why? |
| Electrocardiography | 3 | 2020 | 3957 | 0.05 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.05 | Why? |
| Prostaglandin-E Synthases | 1 | 2019 | 21 | 0.05 | Why? |
| Carcinoma, Squamous Cell | 1 | 2009 | 902 | 0.05 | Why? |
| Agrobacterium | 1 | 2019 | 6 | 0.05 | Why? |
| Cyclooxygenase Inhibitors | 1 | 2019 | 46 | 0.05 | Why? |
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2019 | 4 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.05 | Why? |
| Pueraria | 1 | 2019 | 2 | 0.05 | Why? |
| Mice, Knockout, ApoE | 1 | 2019 | 42 | 0.05 | Why? |
| Cetuximab | 1 | 2019 | 35 | 0.05 | Why? |
| Indomethacin | 1 | 2019 | 47 | 0.05 | Why? |
| Seedlings | 1 | 2018 | 13 | 0.05 | Why? |
| Leucovorin | 1 | 2019 | 70 | 0.05 | Why? |
| Porphobilinogen | 1 | 2018 | 6 | 0.05 | Why? |
| Glycolipids | 1 | 2018 | 19 | 0.05 | Why? |
| 1-Deoxynojirimycin | 1 | 2018 | 18 | 0.05 | Why? |
| Plant Viruses | 1 | 2018 | 34 | 0.05 | Why? |
| Enzyme Assays | 1 | 2020 | 295 | 0.05 | Why? |
| Chloroplasts | 1 | 2018 | 38 | 0.05 | Why? |
| Coronary Angiography | 2 | 2020 | 2275 | 0.05 | Why? |
| ADP-ribosyl Cyclase 1 | 1 | 2019 | 96 | 0.05 | Why? |
| Metalloendopeptidases | 1 | 2018 | 35 | 0.05 | Why? |
| Injection, Intratympanic | 1 | 2018 | 16 | 0.05 | Why? |
| Radiation Tolerance | 1 | 2018 | 25 | 0.05 | Why? |
| MAP Kinase Kinase Kinase 2 | 1 | 2018 | 2 | 0.05 | Why? |
| Bread | 1 | 2018 | 14 | 0.05 | Why? |
| Caveolin 1 | 1 | 2019 | 73 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2018 | 6153 | 0.05 | Why? |
| Chromosomes, Plant | 1 | 2018 | 19 | 0.05 | Why? |
| Personality Inventory | 1 | 2018 | 72 | 0.05 | Why? |
| Arabidopsis Proteins | 1 | 2018 | 54 | 0.05 | Why? |
| G2 Phase Cell Cycle Checkpoints | 1 | 2018 | 25 | 0.05 | Why? |
| Sex Chromosome Aberrations | 1 | 2018 | 4 | 0.05 | Why? |
| Biological Control Agents | 1 | 2018 | 5 | 0.05 | Why? |
| Dinoprostone | 1 | 2019 | 101 | 0.05 | Why? |
| Chromosome Banding | 1 | 2017 | 3 | 0.05 | Why? |
| Cytogenetic Analysis | 1 | 2018 | 21 | 0.05 | Why? |
| Health Promotion | 1 | 2012 | 2020 | 0.05 | Why? |
| POU Domain Factors | 1 | 2017 | 1 | 0.05 | Why? |
| Acclimatization | 1 | 2019 | 69 | 0.05 | Why? |
| Surgical Procedures, Operative | 1 | 2015 | 2662 | 0.05 | Why? |
| Radiation, Ionizing | 1 | 2018 | 39 | 0.05 | Why? |
| Ethylenediamines | 1 | 2017 | 6 | 0.05 | Why? |
| Chromosomes, Human, Pair 17 | 1 | 2017 | 13 | 0.05 | Why? |
| Phenylephrine | 1 | 2017 | 20 | 0.05 | Why? |
| Oncogenes | 1 | 2018 | 23 | 0.05 | Why? |
| Aflatoxin B1 | 1 | 2018 | 13 | 0.05 | Why? |
| Prolamins | 1 | 2017 | 1 | 0.05 | Why? |
| Chromosomes, Human, Pair 1 | 1 | 2017 | 11 | 0.05 | Why? |
| Growth Charts | 1 | 2017 | 18 | 0.05 | Why? |
| Myoblasts | 1 | 2017 | 24 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Receptors, Lysosphingolipid | 1 | 2017 | 25 | 0.05 | Why? |
| Endocardium | 1 | 2019 | 90 | 0.05 | Why? |
| Photic Stimulation | 1 | 2018 | 74 | 0.05 | Why? |
| Fluorouracil | 1 | 2019 | 169 | 0.05 | Why? |
| Dentition, Mixed | 1 | 2017 | 1 | 0.05 | Why? |
| RAW 264.7 Cells | 1 | 2019 | 316 | 0.05 | Why? |
| Gene Duplication | 1 | 2017 | 31 | 0.05 | Why? |
| Codon, Terminator | 1 | 2018 | 72 | 0.05 | Why? |
| Sterigmatocystin | 1 | 2017 | 1 | 0.05 | Why? |
| Ventricular Myosins | 1 | 2017 | 1 | 0.05 | Why? |
| Lepidoptera | 1 | 2017 | 26 | 0.05 | Why? |
| Amniocentesis | 1 | 2017 | 25 | 0.05 | Why? |
| A Kinase Anchor Proteins | 1 | 2017 | 14 | 0.04 | Why? |
| Rho Guanine Nucleotide Exchange Factors | 1 | 2017 | 10 | 0.04 | Why? |
| Decompression, Surgical | 1 | 2019 | 114 | 0.04 | Why? |
| Frameshift Mutation | 1 | 2018 | 158 | 0.04 | Why? |
| Calcineurin | 1 | 2017 | 38 | 0.04 | Why? |
| DNA, Fungal | 1 | 2018 | 95 | 0.04 | Why? |
| Diastole | 1 | 2018 | 168 | 0.04 | Why? |
| Quinolinic Acids | 1 | 2017 | 1 | 0.04 | Why? |
| DNA Transposable Elements | 1 | 2018 | 91 | 0.04 | Why? |
| Antineoplastic Agents, Alkylating | 1 | 2018 | 71 | 0.04 | Why? |
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 28 | 0.04 | Why? |
| Sinoatrial Node | 1 | 2017 | 22 | 0.04 | Why? |
| Nerve Growth Factor | 1 | 2017 | 38 | 0.04 | Why? |
| Calcium Chloride | 1 | 2017 | 4 | 0.04 | Why? |
| Deoxyguanosine | 1 | 2017 | 19 | 0.04 | Why? |
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 12 | 0.04 | Why? |
| Intensive Care Units | 3 | 2020 | 29594 | 0.04 | Why? |
| KCNQ1 Potassium Channel | 1 | 2017 | 10 | 0.04 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.04 | Why? |
| Specific Pathogen-Free Organisms | 1 | 2019 | 358 | 0.04 | Why? |
| Cathepsins | 1 | 2019 | 204 | 0.04 | Why? |
| Naphthyridines | 1 | 2017 | 48 | 0.04 | Why? |
| Nursing Assessment | 1 | 2018 | 72 | 0.04 | Why? |
| Heterografts | 1 | 2018 | 203 | 0.04 | Why? |
| Hedgehog Proteins | 1 | 2017 | 39 | 0.04 | Why? |
| Basic-Leucine Zipper Transcription Factors | 1 | 2017 | 19 | 0.04 | Why? |
| HMGB1 Protein | 1 | 2020 | 223 | 0.04 | Why? |
| X-Ray Microtomography | 1 | 2017 | 115 | 0.04 | Why? |
| Cell Transdifferentiation | 1 | 2017 | 47 | 0.04 | Why? |
| Fetal Hemoglobin | 1 | 2017 | 22 | 0.04 | Why? |
| Recurrence | 2 | 2019 | 3675 | 0.04 | Why? |
| Plant Breeding | 1 | 2017 | 29 | 0.04 | Why? |
| Thiocarbamates | 1 | 2017 | 31 | 0.04 | Why? |
| Crops, Agricultural | 1 | 2018 | 88 | 0.04 | Why? |
| Chromosomes | 1 | 2017 | 17 | 0.04 | Why? |
| Diet Surveys | 1 | 2018 | 152 | 0.04 | Why? |
| Zea mays | 1 | 2017 | 24 | 0.04 | Why? |
| Follicle Stimulating Hormone | 1 | 2017 | 73 | 0.04 | Why? |
| Tibet | 1 | 2017 | 80 | 0.04 | Why? |
| Radiography, Dental | 1 | 2017 | 38 | 0.04 | Why? |
| Child Abuse, Sexual | 1 | 2017 | 42 | 0.04 | Why? |
| Self-Assessment | 1 | 2018 | 165 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2018 | 274 | 0.04 | Why? |
| Neurotoxins | 1 | 2017 | 42 | 0.04 | Why? |
| Systole | 1 | 2018 | 252 | 0.04 | Why? |
| Atrial Natriuretic Factor | 1 | 2017 | 75 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.04 | Why? |
| Sperm Count | 1 | 2017 | 72 | 0.04 | Why? |
| Bone Remodeling | 1 | 2017 | 59 | 0.04 | Why? |
| Anthocyanins | 1 | 2017 | 51 | 0.04 | Why? |
| Snacks | 1 | 2018 | 231 | 0.04 | Why? |
| Perfusion | 1 | 2018 | 254 | 0.04 | Why? |
| Interleukin-13 | 1 | 2018 | 204 | 0.04 | Why? |
| Cell Cycle Proteins | 1 | 2019 | 297 | 0.04 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2018 | 202 | 0.04 | Why? |
| Maxilla | 1 | 2017 | 70 | 0.04 | Why? |
| Kruppel-Like Transcription Factors | 1 | 2017 | 91 | 0.04 | Why? |
| Sperm Motility | 1 | 2017 | 106 | 0.04 | Why? |
| Postpartum Hemorrhage | 1 | 2018 | 144 | 0.04 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2017 | 207 | 0.04 | Why? |
| Cone-Beam Computed Tomography | 1 | 2017 | 118 | 0.04 | Why? |
| Geographic Mapping | 1 | 2018 | 247 | 0.04 | Why? |
| Baltimore | 1 | 2017 | 220 | 0.04 | Why? |
| DNA Helicases | 1 | 2018 | 203 | 0.04 | Why? |
| Losartan | 1 | 2017 | 86 | 0.04 | Why? |
| Meals | 1 | 2018 | 205 | 0.04 | Why? |
| Nucleic Acid Hybridization | 1 | 2017 | 140 | 0.04 | Why? |
| Practice Guidelines as Topic | 2 | 2018 | 15421 | 0.04 | Why? |
| Macrophage Activation | 1 | 2019 | 315 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
| Pituitary-Adrenal System | 1 | 2017 | 135 | 0.04 | Why? |
| Cytidine Deaminase | 1 | 2017 | 109 | 0.04 | Why? |
| Cell Transformation, Neoplastic | 1 | 2018 | 191 | 0.04 | Why? |
| Muscle, Smooth, Vascular | 1 | 2017 | 86 | 0.04 | Why? |
| Cellular Reprogramming | 1 | 2017 | 117 | 0.04 | Why? |
| Interleukin-2 | 1 | 2018 | 443 | 0.04 | Why? |
| Pregnancy Rate | 1 | 2017 | 134 | 0.04 | Why? |
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 279 | 0.04 | Why? |
| Ubiquitination | 1 | 2018 | 343 | 0.04 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2019 | 310 | 0.04 | Why? |
| Tumor Burden | 1 | 2018 | 369 | 0.04 | Why? |
| Aggression | 1 | 2017 | 126 | 0.04 | Why? |
| Heterocyclic Compounds, 4 or More Rings | 1 | 2017 | 139 | 0.04 | Why? |
| Minocycline | 1 | 2017 | 101 | 0.04 | Why? |
| Maryland | 1 | 2018 | 436 | 0.04 | Why? |
| Infant, Small for Gestational Age | 1 | 2017 | 151 | 0.04 | Why? |
| Neoplasms, Multiple Primary | 1 | 2017 | 61 | 0.04 | Why? |
| Factor Analysis, Statistical | 1 | 2018 | 538 | 0.04 | Why? |
| Age Factors | 4 | 2018 | 21039 | 0.04 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2020 | 365 | 0.04 | Why? |
| Microspheres | 1 | 2018 | 261 | 0.04 | Why? |
| Depression | 2 | 2017 | 14116 | 0.04 | Why? |
| Preoperative Period | 1 | 2017 | 271 | 0.04 | Why? |
| Cross-Cultural Comparison | 1 | 2018 | 338 | 0.04 | Why? |
| Mortality, Premature | 1 | 2017 | 111 | 0.04 | Why? |
| Maternal-Child Health Services | 1 | 2017 | 124 | 0.04 | Why? |
| Myocytes, Smooth Muscle | 1 | 2017 | 127 | 0.04 | Why? |
| Molecular Sequence Annotation | 1 | 2018 | 478 | 0.04 | Why? |
| Apolipoproteins E | 1 | 2017 | 170 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2017 | 400 | 0.04 | Why? |
| Hallucinations | 1 | 2017 | 122 | 0.04 | Why? |
| Radiation Exposure | 1 | 2018 | 161 | 0.04 | Why? |
| Hypothalamo-Hypophyseal System | 1 | 2017 | 187 | 0.04 | Why? |
| Occupational Injuries | 1 | 2018 | 148 | 0.04 | Why? |
| Quantitative Trait Loci | 1 | 2017 | 340 | 0.04 | Why? |
| Ubiquitin-Protein Ligases | 1 | 2018 | 249 | 0.04 | Why? |
| Observer Variation | 1 | 2018 | 622 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2017 | 501 | 0.04 | Why? |
| Pregnancy Complications, Hematologic | 1 | 2017 | 114 | 0.04 | Why? |
| Logical Observation Identifiers Names and Codes | 1 | 2015 | 35 | 0.04 | Why? |
| Gene Ontology | 1 | 2017 | 391 | 0.04 | Why? |
| Poultry | 1 | 2017 | 437 | 0.04 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.04 | Why? |
| Immunoglobulin E | 1 | 2018 | 557 | 0.04 | Why? |
| Ultrasonography, Interventional | 1 | 2020 | 560 | 0.04 | Why? |
| Carotid Stenosis | 1 | 2018 | 207 | 0.04 | Why? |
| Nucleotides | 1 | 2017 | 212 | 0.04 | Why? |
| Occupational Therapy | 1 | 2018 | 228 | 0.03 | Why? |
| Bone and Bones | 1 | 2017 | 235 | 0.03 | Why? |
| Protein Stability | 1 | 2017 | 756 | 0.03 | Why? |
| Coronary Stenosis | 1 | 2018 | 273 | 0.03 | Why? |
| Focus Groups | 1 | 2018 | 811 | 0.03 | Why? |
| Culture | 1 | 2018 | 370 | 0.03 | Why? |
| Bone Density | 1 | 2017 | 335 | 0.03 | Why? |
| Self Concept | 1 | 2018 | 490 | 0.03 | Why? |
| Point Mutation | 1 | 2017 | 481 | 0.03 | Why? |
| Fluorescent Antibody Technique | 1 | 2016 | 835 | 0.03 | Why? |
| Bradycardia | 1 | 2017 | 292 | 0.03 | Why? |
| Equipment and Supplies | 1 | 2018 | 440 | 0.03 | Why? |
| Radiopharmaceuticals | 1 | 2018 | 763 | 0.03 | Why? |
| Industry | 1 | 2017 | 347 | 0.03 | Why? |
| Candidiasis | 1 | 2017 | 334 | 0.03 | Why? |
| Narration | 1 | 2014 | 143 | 0.03 | Why? |
| Job Satisfaction | 1 | 2018 | 647 | 0.03 | Why? |
| Pyrrolidines | 1 | 2017 | 558 | 0.03 | Why? |
| Health Services Accessibility | 1 | 2017 | 10697 | 0.03 | Why? |
| Stem Cells | 1 | 2019 | 595 | 0.03 | Why? |
| Administration, Oral | 1 | 2020 | 2340 | 0.03 | Why? |
| Troponin T | 1 | 2018 | 771 | 0.03 | Why? |
| Adenosine | 1 | 2017 | 509 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.03 | Why? |
| A549 Cells | 1 | 2018 | 2066 | 0.03 | Why? |
| Databases, Genetic | 1 | 2018 | 1127 | 0.03 | Why? |
| Secondary Prevention | 1 | 2017 | 762 | 0.03 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.03 | Why? |
| Molecular Structure | 1 | 2017 | 1539 | 0.03 | Why? |
| Cognition Disorders | 1 | 2017 | 574 | 0.03 | Why? |
| Autoimmunity | 1 | 2019 | 841 | 0.03 | Why? |
| Flow Cytometry | 1 | 2020 | 2393 | 0.03 | Why? |
| Sex Distribution | 1 | 2019 | 2083 | 0.03 | Why? |
| Elasticity | 1 | 2010 | 70 | 0.03 | Why? |
| Patient Participation | 1 | 2018 | 829 | 0.03 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2018 | 1153 | 0.03 | Why? |
| Urinary Tract Infections | 1 | 2017 | 534 | 0.03 | Why? |
| Linkage Disequilibrium | 1 | 2011 | 191 | 0.03 | Why? |
| Psychometrics | 1 | 2018 | 1269 | 0.03 | Why? |
| Nasal Mucosa | 1 | 2018 | 1218 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Anxiety | 1 | 2017 | 17311 | 0.03 | Why? |
| Gene Expression Regulation, Viral | 1 | 2016 | 925 | 0.03 | Why? |
| Cell Growth Processes | 1 | 2009 | 12 | 0.03 | Why? |
| DNA, Antisense | 1 | 2009 | 7 | 0.03 | Why? |
| Geography | 1 | 2017 | 1801 | 0.03 | Why? |
| Educational Status | 1 | 2017 | 1451 | 0.03 | Why? |
| Social Work | 1 | 2018 | 598 | 0.03 | Why? |
| Virulence | 1 | 2017 | 2172 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.03 | Why? |
| Interpersonal Relations | 1 | 2018 | 926 | 0.03 | Why? |
| United States | 4 | 2018 | 46150 | 0.03 | Why? |
| Metformin | 1 | 2017 | 640 | 0.03 | Why? |
| Histone Deacetylases | 1 | 2009 | 37 | 0.03 | Why? |
| Anemia | 1 | 2017 | 789 | 0.03 | Why? |
| Electroencephalography | 1 | 2017 | 1242 | 0.02 | Why? |
| Medicare | 1 | 2017 | 1048 | 0.02 | Why? |
| Polymerase Chain Reaction | 2 | 2018 | 6740 | 0.02 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.02 | Why? |
| Mice, Transgenic | 1 | 2017 | 2739 | 0.02 | Why? |
| Rats, Wistar | 1 | 2011 | 621 | 0.02 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.02 | Why? |
| Disasters | 1 | 2018 | 760 | 0.02 | Why? |
| Physical Therapy Modalities | 1 | 2018 | 1090 | 0.02 | Why? |
| Age Distribution | 1 | 2019 | 3567 | 0.02 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Workflow | 1 | 2018 | 2373 | 0.02 | Why? |
| Small Molecule Libraries | 1 | 2017 | 1060 | 0.02 | Why? |
| Hemorrhage | 1 | 2021 | 3013 | 0.02 | Why? |
| Thrombolytic Therapy | 1 | 2020 | 2218 | 0.02 | Why? |
| Hydrocortisone | 1 | 2018 | 1790 | 0.02 | Why? |
| Research Personnel | 1 | 2018 | 1037 | 0.02 | Why? |
| Membrane Glycoproteins | 1 | 2017 | 2273 | 0.02 | Why? |
| Phosphothreonine | 1 | 2006 | 2 | 0.02 | Why? |
| Oxygenases | 1 | 2006 | 6 | 0.02 | Why? |
| Apigenin | 1 | 2006 | 14 | 0.02 | Why? |
| Blood Pressure Monitoring, Ambulatory | 1 | 2010 | 341 | 0.02 | Why? |
| Hospitals, Pediatric | 1 | 2018 | 1792 | 0.02 | Why? |
| Psychotic Disorders | 1 | 2017 | 924 | 0.02 | Why? |
| Repressor Proteins | 1 | 2009 | 232 | 0.02 | Why? |
| Bayes Theorem | 1 | 2017 | 3237 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Chromones | 1 | 2006 | 42 | 0.02 | Why? |
| Inositol | 1 | 2006 | 28 | 0.02 | Why? |
| Serine | 1 | 2006 | 90 | 0.02 | Why? |
| Family Characteristics | 1 | 2018 | 2551 | 0.02 | Why? |
| Quality of Life | 2 | 2018 | 9820 | 0.02 | Why? |
| Leukocyte Count | 1 | 2017 | 3178 | 0.02 | Why? |
| Lymphatic Metastasis | 1 | 2009 | 537 | 0.02 | Why? |
| Residence Characteristics | 1 | 2017 | 1927 | 0.02 | Why? |
| Environmental Exposure | 1 | 2017 | 1558 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Drug Synergism | 1 | 2009 | 833 | 0.02 | Why? |
| Genetic Vectors | 1 | 2013 | 1600 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.02 | Why? |
| Genomics | 1 | 2017 | 3118 | 0.02 | Why? |
| Employment | 1 | 2017 | 1754 | 0.02 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.02 | Why? |
| Australia | 1 | 2018 | 6306 | 0.02 | Why? |
| Poverty | 1 | 2017 | 2302 | 0.02 | Why? |
| Morpholines | 1 | 2006 | 351 | 0.02 | Why? |
| Aorta, Thoracic | 1 | 2006 | 271 | 0.02 | Why? |
| Biosensing Techniques | 1 | 2018 | 2116 | 0.02 | Why? |
| Attitude to Health | 1 | 2017 | 2002 | 0.02 | Why? |
| Family | 1 | 2018 | 2909 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Palliative Care | 1 | 2018 | 2665 | 0.02 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.01 | Why? |
| Occupational Diseases | 1 | 2018 | 2787 | 0.01 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.01 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2011 | 2309 | 0.01 | Why? |
| Zinc | 1 | 2009 | 817 | 0.01 | Why? |
| Molecular Diagnostic Techniques | 1 | 2018 | 4239 | 0.01 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.01 | Why? |
| Air Pollutants | 1 | 2017 | 3110 | 0.01 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.01 | Why? |
| Information Dissemination | 1 | 2015 | 2986 | 0.01 | Why? |
| Exercise | 1 | 2019 | 6771 | 0.01 | Why? |
| Registries | 1 | 2017 | 12327 | 0.01 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2009 | 3550 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.01 | Why? |
| Breast Neoplasms | 1 | 2009 | 3633 | 0.01 | Why? |
| Public Health | 1 | 2017 | 16359 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2017 | 15909 | 0.01 | Why? |
| RNA, Viral | 1 | 2016 | 32276 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2013 | 21571 | 0.01 | Why? |